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ABSTRACT 
Kevin Perry Dobmeier: Xerogel Coatings for Biomedical Sensing Applications 
(Under the direction of Professor Mark H. Schoenfisch) 
 
 New strategies for utilizing sol-gel chemistry to improve sensor compatibility with 
physiological environments and produce xerogel membranes for novel optical sensor 
applications are described.  Incorporation of nitric oxide (NO)-donor functionalities into a 
material is an established means of creating more biocompatible blood and tissue-contacting 
surfaces. A NO-releasing optical pH sensor designed for intravascular use was developed 
through covalent attachment of N-diazeniumdiolate (NONOate) NO donors to 
aminoalkoxysilane-derived xerogels. A two-layer sensor configuration was employed 
wherein a NONOate-modified xerogel and porous tetramethyl orthosilicate xerogel 
containing a fluorescent pH indicator were sequentially dip-coated onto a tapered fiber-optic 
probe.  The resulting sensors were capable of rapid and linear optical pH detection 
throughout the physiological pH range (7.0 - 7.8 pH) and generated NO fluxes >0.4 pmol cm-
2 s-1 for ~16 h.  Significant reductions of platelet adhesion to the NO-releasing materials 
versus controls were observed after exposure to platelet-enriched porcine plasma. 
 An alternate class of NO-releasing xerogels was formed by co-condensation of 
mercaptoalkoxysilane and alkylalkoxysilane sol-gel precursors.  Subsequent thiol 
nitrosation resulted in S-nitrosothiol (RSNO)-modified xerogels capable of generating NO-
fluxes >0.5 pmol cm-2 s-1 for up to 14 d in 37 °C phosphate-buffered saline (PBS).  The 
 iii 
films displayed excellent solution stability with larger percentages of NO-donor inclusion 
than NONOate-modified films.  Reductions observed in platelet and Pseudomonas 
aeruginosa adhesion to nitrosated films versus non-nitrosated controls confirmed the 
antithrombotic and antibacterial properties of the materials.  
Aminoalkoxysilane-derived xerogels were further employed to create optical sensor 
coatings for quantitative detection of nitroxyl (HNO), the one-electron reduced congener of 
NO.  A kinetic strategy was used to quantify HNO via the spectroscopically observed rates 
of HNO-induced reductive manganese(III) meso-tetrakis(4-sulfonatophenyl) porphyrinate 
(MnIIITPPS) nitrosylation.  The stability of the MnII(NO)TPPS reaction product was 
significantly increased when encapsulated in the anaerobic interior of an 
(aminoethylaminomethyl)phenethyltrimethoxysilane (AEMP3)-derived xerogel film. 
Nitroxyl diffusion through the xerogel materials was selectively enhanced via the covalent 
incorporation of trimethoxysilyl-terminated poly(amidoamine-organosilicon) (PAMAMOS) 
dendrimers, resulting in substantially increased sensitivity to HNO.  The HNO-sensing 
films were subsequently employed in a 96-well microtitre plate format to characterize HNO 
release from a recently described HNO/NO donor compound, sodium-1-
(isopropylamino)diazene-1-ium-1,2-diolate (IPA/NO). 
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Chapter 1: 
Xerogel Technology in Sensor Applications 
 
1.1. Xerogels 
Sol-gel chemistry is a useful and versatile means of producing ceramic materials from 
simple metal or metalloid precursors.  During the sol-gel process, three-dimensional 
networking transforms a stabilized colloidal suspension of particles, termed a sol, into a 
unified macroscopic molecule extending throughout the liquid bulk, termed a gel.1  
Subsequent removal of the solvent results in the formation of a solid ceramic material called 
a xerogel, the character and morphology of which can be widely controlled through changes 
over various aspects of the sol-gel process, including the starting reagents,2, 3 catalyst,4, 5 
reaction environment,6, 7 and drying conditions utilized.8, 9   Because of the relatively mild 
reaction conditions and fine control allowed over the physical and chemical properties of the 
resultant material, sol-gel processing has been widely employed in analytical chemistry as a 
means of producing scaffolds and host matrices for chemical indicators and transducing 
molecules in the fabrication of chemical sensors.10, 11  My doctoral work has focused on 
strategies to best employ the unique capabilities of sol-gel processing for the design and 
development of coatings for biomedical sensors and devices. 
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1.1.1. Sol-Gel Chemistry
The history of sol-gel chemistry can be traced as far back as 1845 and the first 
reported synthesis of an alkoxysilane reagent, tetraethylorthosilicate (Si(OEt)4; TEOS) by 
Ebelmen.12  Ebelmen observed that TEOS solutions exposed to the atmosphere would gel 
over time, and this has been the basis for all sol-gel chemistry that has followed.  Sol-gel 
derived materials may be formed from a large number of metal alkoxide compounds, 
including the early transition metals (e.g., Ti, V, Zr) and Group IIIB metals such as B and Al. 
The most widely studied and developed sol-gel materials by far are silicate ceramics formed 
by reaction of alkoxysilane precursors.1  Such materials are favored due to the inert nature of 
the final silicate network and relative simplicity of the chemistry of tetravalent Si compared 
to other transition metals.  As nearly all sol-gel-derived sensors rely on silica-based 
materials,10, 11 the following discussion will focus exclusively on alkoxysilane-based 
xerogels. 
Sol-gel chemistry is based on three reactions: the hydrolysis, and the alcohol and 
water condensation of alkoxysilane precursors into siloxane-bonded networks (Reactions 1.1-
1.3, respectively). 
≡Si-OR + H2O ⇄ ≡Si-OH + ROH    (1.1) 
≡Si-OR + HO-Si≡ ⇄ ≡Si-O-Si≡ + ROH   (1.2) 
≡Si-OH + HO-Si≡ ⇄ ≡Si-O-Si≡ + H2O   (1.3) 
All three reactions proceed simultaneously. Water and alkoxysilanes are immiscible and thus 
an alcohol co-solvent (e.g., ethanol or methanol) is typically employed to speed hydrolysis, 
though it is not always required.  Alcohol produced as a byproduct of Reactions 1.1 and 1.2 
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has been found sufficient to homogenize the solution in some cases.13  Hydrolysis and 
condensation reactions are responsible for both initial colloid nucleation and subsequent 
networking and gel formation.  The relative rates of the three reactions determine in large 
part the final properties of the xerogel material.  Under conditions where hydrolysis rates 
exceed condensation, high concentrations of readily accessible reactive monomer in solution 
lead to the production of large silane aggregates and large particulate sols.  The result upon 
drying is a bulky, porous, highly branched xerogel network.  Conversely, if condensation 
rates far outstrip the reservoir of hydrolyzed monomers, weakly branched polymeric sols 
comprised of long interwoven siloxane chains are formed.  Xerogels formed under these 
conditions tend to be denser and less porous materials. 
 The kinetics of hydrolysis and condensation, and thus the final properties of a 
homogenous xerogel material, are affected mainly by 3 reaction parameters:  the water to 
silane molar ratio,6 the pH of the sol,4 and the steric accessibility of the alkoxy leaving 
group.14  A high water to silane ratio will speed hydrolysis reactions and retard rates of 
condensation.  Conversely, bulky alkoxy functionalities or branched alkyl-side chains on 
silane precursors can sterically hinder hydrolysis, shifting the relative rates of reaction in 
favor of condensation.  Sol pH provides a third avenue of control.  Sol-gel reactions are 
typically catalyzed by the addition of acid or base, most often mineral acids (e.g., HCl) or 
ammonia, respectively.1  As shown in Figure 1.1, the catalyst employed affects the 
mechanism of gel hydrolysis.  In general, more acidic conditions favor condensation over 
hydrolysis resulting in the production of denser films.  At pH < 2 where the polymerization 
rate is proportional to [H]+, silica solubility is low and gel networks are formed of small 
particles with diameters < 2 nm.15  From pH 2-6, gelation rates increase with increasing 
 4
A
B
Figure 1.1. Mechanism of sol-gel precursor hydrolysis under (A) acid-catalyzed 
and (B) base-catalyzed conditions.  
 5
[OH]- and particles grow by the preferential condensation of highly condensed oligomers 
with smaller neutral species to diameters of ~2-4 nm.  At pH > 7, condensed species are 
largely ionized, leading to greatly increased silica solubility and charge-charge repulsion 
between particles.  Particles grow via Ostwald ripening and the dissolution of smaller 
particles and deposition of silica onto larger particles.1  Silica solubility (and hence maximum 
particle diameter) is controlled largely by temperature.  Particles can reach sizes >100 nm.15  
In this manner, stable sols containing large diameter silica nanoparticles may be created in 
high pH conditions. 
 
1.1.2. Xerogel Properties 
Xerogels have a number of physical and chemical properties that prove useful for the 
production of chemical sensors and biosensors.  Xerogels formed via the reaction of 
tetraalkoxysilane precursors such as TEOS or tetramethyl orthosilicate (TMOS) are 
chemically inert, glass-like materials with a high degree of mechanical and chemical 
stability.  Such films are generally porous, and the pore-size distribution is easily controlled 
via the reaction conditions employed (vide supra).  Xerogels often exhibit useful optical 
properties such as high refractive indices and transparency to visible light.16  They adhere 
well to glass and silica substrates and may form covalent linkages to terminal silanol groups 
on the glass surface.17, 18  Xerogels may also be produced at low temperatures, allowing for 
the incorporation of organic molecules and polymers and sustaining the activity of doped 
enzymes and biomolecules.19   
Perhaps the greatest overall advantage of sol-gel chemistry is the extreme versatility and 
ease of xerogel network modification.  The structure of a sol-gel derived material can vary 
greatly depending on the processing and drying conditions employed.  Thin films, fibers, 
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monoliths, and powders may all be formed.3, 20  Extremely porous aerogels having solid 
volume fractions as low as 1% may be created under supercritical-drying conditions whereby 
gel shrinkage due to capillary pressure from the liquid/vapor interface is avoided.21  Each 
material form has advantages.  Thin films may be applied to a variety of sensing platforms 
and offer short analyte diffusion path lengths through the material.10 Bulk monoliths may be 
molded to a desired form and offer longer optical path lengths for spectroscopic 
measurements.22  Powders and aerogels are not typically employed in analytical sensing 
applications, but their high surface areas are of practical use in catalysis.21, 23  By exerting 
proper control over sol-gel processing conditions, the final material is readily tailored to a 
desired application.  
Another common avenue of xerogel modification is through the use of organically 
modified silane precursors, wherein one or more alkoxy groups of a silane is replaced with a 
desired organic side chain.  Incorporating organic character into the silicate network can 
produce fundamental changes in the properties of the xerogel.  For example,  Rao et al. 
reported increased hydrophobicity of aerogels formed from alkylalkoxysilane precursors with 
an increasing number of alkyl units in the organic side chain.2  Organoalkoxysilanes allow 
numerous functionalities (e.g., amines, thiols, epoxides) to be covalently incorporated as 
pendant additions to the siloxane backbone.3, 20  The result can affect not only bulk physical 
properties of the xerogel material,16, 24 but also provides a means of including specific 
localized reaction sites in the xerogel microenvironment. Thus appropriate 
organoalkoxysilanes may be employed for sensor applications to create more open or 
lipophilic sensor membranes or provide sites for direct covalent attachment of chemical 
indicators. 
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1.2.    Xerogel-Based Sensors 
 
1.2.1. Optical Xerogel Sensors 
 The chemical stability, porosity, and optically transparency of xerogels make them 
nearly ideal as a host matrix for optical dyes and indicators, and it is in this sensing format 
that xerogels have been most often used in sensing applications.  Since Avnir and co-workers 
first reported the incorporation of Rhodamine 6G, a fluorescent indicator molecule, in a 
xerogel matrix in 1984,25 xerogel-based optical sensing has advanced rapidly.  Three general 
methods may be employed to immobilize fluorophores or colorimetric indicators in a host 
xerogel: impregnation, covalent binding, or doping.26, 27  Impregnation involves simple 
physical or chemical adsorption (e.g., electrostatic interaction) of optical indicator species 
onto the glass surface of a preformed xerogel.  Dye/matrix association is generally short-
lived in these cases, making impregnation typically unsuitable for most sensing 
applications.28  Covalent binding of an indicator to the xerogel matrix via specific organic 
functionalities allows permanent immobilization of dyes in a sensor and ends leaching 
concerns.29, 30  Unfortunately, covalent binding also has a tendency to lengthen sensor 
response times and decrease overall sensitivity due to reductions in the bound fluorophore’s 
degrees of freedom and corresponding fluorescence intensity.31  Doping strategies, wherein 
optical indicators and dyes are incorporated into the sol prior to gel formation, are the most 
widely employed means of creating xerogel optical sensors.28  After gel formation and curing 
procedures, the dyes become physically entrapped in the cross-linked xerogel matrix.  As 
such, indicator retention in the xerogel is enhanced while fluorophore rotational freedom is 
maintained.  While dye leaching can still pose a problem during long term exposure of 
 8
indicator-doped xerogels to solution,32, 33 numerous xerogel-based optical sensors with rapid 
response times and high signal stability have been reported.11, 26 
 Optical sensors may be formed from indicator-doped xerogel materials in a number of 
ways.  The most common strategy is deposition of a thin xerogel film onto the surface of an 
optical fiber or waveguide material.26  Numerous studies have utilized xerogel thin films in 
this manner to create optical sensors using both extrinsic and intrinsic sensing configurations 
(Figure 1.2).11  For extrinsic optical sensor configurations (Fig 1.2A), light is guided to and 
from the indicator via optical fibers or waveguides.  The xerogel matrix is used strictly as a 
scaffold or support for the indicator species.  For example, Li et al. recently described a 
wide-range optical pH sensor formed by doping a novel pH indicator, 10-(4-aminophenyl)-
5,15-dimesitylcorrole, in a TEOS xerogel membrane.34  The indicator-doped-xerogel material 
was coated onto glass slides immersed in a flow-cell chamber. A bifurcated optical fiber was 
used to shuttle excitation light and the resultant fluorescent emission to and from the sample.  
Conversely, intrinsic sensing configurations (Fig 1.2B) utilize the xerogel coating itself as an 
integral part of the sensor design.  The refractive properties of the xerogel are utilized to 
guide exciting and emitted light.  Interrogation of an encapsulated fluorescent indicator is 
often accomplished via the penetration of an evanescent wave from the light-guide core to 
the doped-xerogel cladding material.  For example, O’Keeffe and co-workers described the 
fabrication of a LED-driven O2 sensor based on the quenching of RuII-tris(4,7-diphenyl-1,10-
phenanthroline) (Ru(dpp)32+) encapsulated in xerogel surrounding a declad multi-mode 
optical fiber.35  A subsequent study illustrated that the observed fluorescence-quenching 
behavior could be tailored for specific O2 concentrations and environments through 
manipulation of the xerogel cladding properties.36    Intrinsic configurations have a number 
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Figure 1.2. General (A) extrinsic and (B) intrinsic xerogel optical sensor 
configurations. 
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of benefits over extrinsic sensing schemes.  As the interrogating light remains guided in the 
material, optical transparency of the surrounding sample is not required.37 Additionally, the 
integrated nature of the light propagation and sensing elements lends itself to easy 
miniaturization.  Both of these properties are important for sensors that are to be used in 
biological environments.11     
As mentioned above, the high level of control allowed over xerogel properties makes 
them useful for imparting selective analyte permeability to sensor membranes.  This 
versatility makes xerogels particularly useful as sensor membranes for dissolved gas 
analytes.11  By tuning the hydrophobicity and wettability of the xerogel network through the 
inclusion of lipophilic alkyl side chains on the sol-gel precursors employed, selectivity for 
dissolved gas species can be enhanced over other interfering species in solution.  Bright and 
co-workers have examined the effect of xerogel network modification on luminophore-doped 
xerogel O2 sensors extensively.38-40  Tao et al. characterized the effect of alkyl side-chain 
length on sensitivity using pin-printed mircroarrays of Ru(dpp)32+-doped xerogels formed 
from TMOS and TEOS precursors and organoalkoxysilanes with alkyl side-chains ranging 
from 1 to 12 carbon units.40 Sensitivity was found to follow O2 diffusion coefficients and 
solubility in the xerogel matrix. Maximum sensitivity was achieved with an 8-carbon chain 
(C8-TMOS).  A subsequent study by Tang et al. demonstrated that the extent of hydrolysis 
and condensation of C8-TMOS/TMOS sols, as determined by sol aging time prior to casting, 
also played a major role in determining film porosity and final O2 sensitivity.38 Bukowski et 
al. found that even greater O2 sensitivities could be achieved using hydrophobic fluorinated 
alkylalkoxysilane precursors in Ru(dpp)32+-doped xerogels.39  Clearly, modification of 
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optical membrane properties through sol-gel chemistry provides a powerful means of 
enhancing sensor performance. 
 
1.2.2. Electrochemical Xerogel Sensors 
Xerogels have also been employed as electrochemical sensing platforms.41  Similar to 
optical sensing formats, xerogels in electrochemical sensors are used in two basic 
configurations.  In the most basic format, xerogels are simply coated as thin films onto the 
surface of conventional macro or microelectrodes.  These films act as scaffolds and 
membranes in a similar manner to extrinsic optical sensors.  An alternate strategy is to 
disperse a conductive material (e.g., carbon powder, 42 or gold43) throughout the sol prior to 
curing of the gel.  When the gel is subsequently dried in monolith form, a composite 
electrode is formed. Though their fabrication is more complicated, sol-gel derived composite 
electrodes have a number of benefits over the more simply prepared coated-metallic 
electrodes.  The monoliths provide a homogenous structure that may be molded to a desired 
form.  Additionally, the conductive surface area of the porous composite material tends to be 
large and fresh surface can be regenerated through simple polishing.44    
Xerogels provide many of the same benefits discussed for optical sensors when used 
in electrochemical sensors.  For example, proper choice of sol-gel processing conditions and 
alkoxysilane precursors can be utilized to control the wettability and gas permeability of 
composite ceramic carbon electrodes.45  Xerogels can also provide a number of benefits more 
tailored to the specific needs of electrochemical sensors.  By incorporating the correct 
functionalities into the xerogel host network, preconcentration of a target analyte may be 
accomplished, resulting in enhanced sensitivity.  Preadsorption of ephedrine onto C18-
modified gels46 or metal ion complexation with covalently bound thiols47 or amines48 are 
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each examples of xerogel-based preconcentration strategies.  In a similar manner, 
permselective membranes for selective screening of charged analytes from solution may also 
be formed by the incorporation of suitable –NH3+ or –COO- groups in the xerogel.49, 50  
Xerogel coatings and composite electrodes also lend themselves well to electrocatalysis.  
Organic or organometallic catalytic sites may be covalently bound or doped into the material 
to alter electron transfer kinetics and reduce necessary overpotentials for certain analytes.  
For example, Wang et al. described a methyltrimethoxysilane (MTMOS)-based composite 
electrode system containing silicomolybdic acid for the catalytic reduction and detection of 
nitrite.51  Tsionsky et al. used a similar cobalt porphyrin-doped xerogel composite electrode 
for the detection of sulfur dioxide, carbon dioxide, and O2.52  Xerogel-doping strategies are 
not limited to amperometric sensing platforms.  Numerous potentiometric xerogel sensors 
containing covalently bound or physically doped ionophores for the detection of ionic species 
(e.g., chloride53, 54 and perchlorate55 anions) have been described.  
One of the most beneficial attributes of xerogel-based electrochemical membranes 
and electrodes is the controllable porosity of the xerogel material.  Small redox-active 
analytes retain large diffusion rates in the open porous silicate network of TEOS and TMOS-
based films.  High sensitivity and rapid response at xerogel-modified electrodes is thus 
maintained.  At the same time, pore size distribution may be tuned to better retain larger 
signal transduction molecules or electrochemical mediators.  This property makes xerogel-
modifed electrodes particularly well-suited for fabricating enzyme-based biosensors, wherein 
the reaction between an immobilized enzyme and target substrate results in the production of 
a redox-active species that can be monitored amperometrically.44 Bulky enzymes are easily 
retained within the confines of a doped-xerogel network, while smaller substrates and 
 13
reaction products are free to diffuse throughout the xerogel scaffold.  Ellerby and co-workers 
first pioneered the fabrication of xerogel-based biosensors by reporting a technique to retain 
the activity of enzymes copper-zinc superoxide dismutase (CuZnSOD), cytochrome c, and 
myoglobin in a sol by returning the sol to neutral pH via the addition of buffer solution after 
acid-catalysis procedures of TMOS xerogels.56  A report of glucose oxidase (GOx) 
immobilization using the same technique soon followed,57 thus creating the basis for the 
design of future amperometric glucose biosensors for continuous subcutaneous glucose 
monitoring – a goal steadily pursued for the last 15  years.58 Sanchez and co-workers were 
the first to monitor GOx activity amperometrically in TMOS-coated electrodes via the 
electro-oxidation of a ferrocene mediator.59  Narang et al. later reported a popular 
“sandwich” configuration where GOx was immobilized between two TEOS xerogel layers 
on the surface of indium tin oxide electrodes.60  Glucose was monitored via amperometric 
response to hydrogen peroxide (H2O2), formed during the enzymatic transformation of 
glucose to gluconic acid. This general scheme has since been utilized multiple times in 
subsequent reports of xerogel-based glucose sensors and other enzyme-doped biosensors.44 
 
1.3. Sensor Biocompatibility 
 Regardless of the performance of xerogel-based sensors in the laboratory, the 
environment in which a sensor is employed can have equally as large an effect on the 
sensor’s performance as the strategies used in its fabrication.  When a sensor is to be used in 
the body, for example, the physiological environment often complicates sensor operation in 
many important ways.61  The term “biocompatibility” is often used to describe how well an 
indwelling sensor is integrated into and functions within biological environments.62, 63  With 
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proper choice of silane precursor molecules and selective incorporation of nitric oxide (NO)-
donor moieties into xerogel materials, strategies have been developed to increase xerogel 
biocompatibility.  
   
1.3.1. Sensor Biofouling 
When a sensor is inserted into blood or tissue, a cascade of events begin that 
ultimately affect sensor performance.61  Blood-contacting devices are quickly coated with 
plasma proteins, and platelets that begin to activate and adhere to the surface of the sensor.64  
Further aggregation of platelets and the formation of a polymeric fibrin mesh throughout the 
mass of cells results in a blood clot, or thrombus.  Thrombus formation is a serious 
impediment to the function of intravascular sensors as the sensor is blocked from the bulk 
blood environment and analytes of interest (Figure 1.3A).65  In worst case scenarios, the mass 
of platelets and cells can lead to severe health problems such as vessel occlusion. Even if 
complete thrombus formation is avoided, the metabolic processes of adhered cells and 
platelets skew localized analyte concentrations and negatively impact the accuracy of sensor 
measurements.64, 66        
 While the threat of thrombus formation is less of a factor for subcutaneous sensors, 
tissue-contacting devices fall victim to other problems. The body’s natural response to 
foreign materials results in the sequestration of tissue-implanted biomaterials within a dense 
avascular collagen capsule, thereby limiting interaction of the device with the surrounding 
environment (Figure 1.3B).67, 68 Additionally, the presence of inflammatory cells and 
macrophages recruited to the wound site skew localized analyte concentrations in a similar 
manner as platelet metabolism affects intravascular sensors.69 With all implanted materials, 
the risk that bacteria adherent to the sensor upon implantation may later result in infection is  
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Figure 1.3. Biofouling of sensor surfaces upon (A) intravascular or (B) 
subcutaneous implantation. 
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great.70  Though stringent sterilization procedures are employed, implant-associated infection 
remains a serious problem.  Indwelling medical devices are responsible for >1,000,000 
hospital-acquired infections per year in the U.S. alone.71  The problem is further exacerbated 
by the tendency of many surface adherent bacteria to form protective exopolysaccharide 
layers called biofilms.70 Biofilms surrounding bacteria act to keep nutrients in and antibiotics 
out, significantly limiting treatment options if an infection does occur.  In many cases, 
ultimate removal of the sensor or biomedical implant is required.71 
 
1.3.2. Nitric Oxide-Releasing Xerogels 
Nitric oxide (NO), a diatomic free radical produced endogenously by hemeproteins 
known as NO synthases,72 may provide a potentially universal solution to several of the 
previously mentioned biofouling issues.  Nitric oxide plays myriad roles in the body and 
functions in processes ranging from vasodilation to neurotransmission.72, 73  Most importantly 
with regards to enhancing sensor biocompatibility, NO is instrumental in the processes 
governing platelet activation,74 wound-healing,75 angiogenesis,76, 77 and body’s immune 
response to foreign pathogens.78  By modifying polymeric sensor coatings to release NO, 
significant antithrombotic,63, 79antibacterial,80 and tissue-integration81 benefits may be 
achieved. 
Sol-gel chemistry is easily tailored to allow the creation of NO-releasing xerogel 
coatings.  These materials have traditionally been formed by covalently incorporating NO-
donor functionalities termed N-diazeniumdiolates (NONOates) into the siloxane polymer 
backbone.  Zwitterionic NONOates are formed by exposure of secondary amines to high 
pressures (e.g., 5 atm) of NO under basic conditions.82  The amine reversibly binds two 
molecules of NO into a stable NONOate structure (Figure 1.4) that essentially stores or 
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Figure 1.4. Mechanism of N-diazeniumdiolate formation and subsequent NO 
release. 
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transports NO until exposed to a proton source (e.g., water).  Reprotonation of the parent 
amine results in NONOate decomposition and the release of two equivalents of NO.  Nablo 
et al. first reported the synthesis of a NO-releasing xerogel coating by co-condensing (3-
trimethoxysilylpropyl)diethylenetriamine (DET3) with isobutyltrimethoxysilane (BTMOS) 
to form a stable xerogel film.83  After curing and drying of the gel, exposure of the pendant 
triamine side-chain of DET3 to 5 atm NO resulted in NONOate formation.  The resulting 
films released NO continuously for up to 24 h.  A number of NONOate-modifed xerogels 
have since been reported by our lab utilizing a variety of aminoalkoxysilanes and 
alkylalkoxysilane precursors (Figure 1.5).84-88  Of note, amine-terminated xerogel films 
formed from 100% aminoalkoxysilanes are not feasible due to poor stability during 
immersion in solution, likely due to charge-charge repulsion of the diamine and triamine side 
chains.88  Incorporation of inert alkylalkoxysilanes in the xerogel network was found to 
drastically increase stability.  As such, NONOate-modified films were generally formed from 
sols limited to ≤40% aminoalkoxysilane (v:v total silane).  Under these constraints, xerogel 
films capable of generating NO fluxes >0.5 pmol cm-2 s-1 for up to 72 h at physiological 
temperatures have been reported.81   
The biocompatibility benefits of NO-releasing xerogel coatings have been thoroughly 
examined.  Robbins et al. reported on the efficacy of N-diazeniumdiolated  
(aminoethylaminomethylphenethyl)trimethoxysilane (AEMP3)/MTMOS xerogel films and 
microarrays for inhibiting platelet activation and adhesion onto glass substrates.86  Nitric 
oxide fluxes as low as 0.4 pmol cm-2 s-1 from micropatterned arrays of raised xerogel lines 
were capable of reducing the thrombogenicity of glass surfaces versus controls during 
exposure to platelet rich porcine plasma.  Nablo et al. examined the antibacterial effects of 
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Figure 1.5. Alkylalkoxysilanes and aminoalkoxysilanes used in production of N-
diazeniumdiolated NO-releasing xerogels. 
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NO-releasing aminohexylaminopropyltrimethoxysilane (AHAP3)/BTMOS xerogel films on 
stainless steel substrates.87 Significant reductions of adhesion by three medically relevant 
bacterial species (i.e., Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus 
epidermidis) on NO-releasing films versus controls were observed during immersion in 
concentrated bacterial cell suspensions.  Subsequent studies have confirmed that the 
antibacterial benefits are maintained with the presence of a protective polyvinylchloride 
(PVC) overlayer,89 under flow-cell conditions,90 and in vivo (rat model.)91  Benefits to 
overall tissue integration imparted by NO-releasing xerogels have also been examined by 
Hetrick and co-workers.81  During 6 week implantation in a rat model, NO-releasing 
AHAP3/BTMOS xerogel-coated silicone rubber demonstrated decreased fibrous capsule 
formation and enhanced vascularization relative to controls, indicating that NO is useful for 
minimizing the detrimental sequestration of implant materials by the natural foreign body 
response.   
 
1.3.3. NO-Releasing Xerogel Sensors 
While significant biocompatibility benefits for implanted materials may be achieved 
via NONOate-modifed xerogel coatings, specific drawbacks associated with their use in 
sensor applications exist.  Exposure to high pressures of NO (necessary for NONOate 
modification) has been found to dramatically increase xerogel cross-linking and decrease 
porosity.92  As such, diffusion of analytes into NO-releasing xerogel membranes is reduced, 
leading to lengthened sensor response times and decreased overall sensitivity.  When 
attempting to utilize NONOate modified xerogel coatings as electrochemical sensor 
membranes, sensor design strategies beyond simple xerogel coating of the electrode must be 
employed.  Using a multilayer glucose biosensor format, Shin et al. doped NO-releasing 
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AHAP3/MTMOS xerogel particles into a polyurethane overlayer surrounding GOx/MTMOS 
at the surface of an electrode.  In this manner, the benefits of NO-release could be achieved 
while maintaining glucose diffusion through the polyurethane to the underlying enzyme 
layer.  Oh et al. used a similar multilayer format using micropatterned arrays of 
AEMP3/MTMOS xerogel lines to create a NO-releasing glucose microsensor.93  In this 
respect, bare regions of GOx/MTMOS-modifed electrode between NO-releasing 
microstructures were retained. Polymer-doping strategies have also been employed to 
improve analyte diffusion through NO-releasing xerogel materials.  Marxer et al. utilized 
hydrophilic polyurethane (HPU) in conjunction with AHAP3 and ethyltrimethoxysilane 
(ETMOS) to create oxygen-permeable hybrid films for the creation of a NO-releasing 
amperometric oxygen sensor.85  Schoenfisch et al. reported a similar strategy using water-
soluble poly(vinylpyrrolidone) (PVP) in AHAP3/BTMOS films to create hydrophilic pockets 
in a NO-releasing glucose sensor membrane.94   
While the previous strategies may be used to create functional NO-releasing 
electrochemical sensors, the common drawback of these membrane modification procedures 
is a reduced overall volume of NO-generating material.  Attainable NO flux intensities and 
durations are thus greatly reduced.  Optical-sensing formats have not been previously utilized 
in the fabrication of NO-releasing xerogel sensors.  The dense cross-linking of NONOate 
modified xerogels may be less problematic for optical sensing configurations, as analyte or 
enzyme-product transport to an underlying electrode surface is not required.  While solution 
permeability is reduced in NONOate modified xerogels, visible light propagation through the 
transparent material should remain unhindered.  Optical sensing strategies should allow the 
use of NONOate modified xerogels without requiring extensive microfabrication or doping 
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procedures, thereby increasing the amount of NO attainable from the sensor.  Evaluating 
NONOate-modified xerogels films as optical sensor membranes was one goal of my doctoral 
work.   
 
1.4. S-Nitrosothiol-Modified Xerogels 
Alternative NO-donor functionalities may also prove useful for improving the 
biocompatibility and function of NO-releasing sensors.  S-nitrosothiols (RSNOs) are one 
class of NO donors that have significant potential in this area.  S-nitrosothiols are readily 
formed by reaction of thiols with reactive nitrogen oxide species (e.g., N2O3, HNO2).95 The 
solution phase antimicrobial96, 97 and antithrombotic98, 99 effects of small-molecule RSNOs 
have been well characterized.  For example, Langford et al. reported on the efficacy of  S-
nitrosoglutathione (GSNO) treatment of patients undergoing percutaneous transluminal 
coronary angioplasty.98  A significant reduction of platelet activation in the GSNO-treated 
patients was observed with no measurable increase in blood pressure. While NO production 
from RSNOs is not as straightforward as the proton-initiated decomposition of NONOates, a 
number of mechanisms have been described triggering NO release from RSNOs.  These 
reactions include thermal and light-initiated homolytic cleavage of the S-N bond,100 catalytic 
reaction with Cu+,101 or a two-step mechanism with other thiols through a nitroxyl (HNO) 
intermediate (Figure 1.6).102  Direct transnitrosation reactions between RSNOs and other 
thiols have also been described,103 indicating that the production of an NO intermediate may 
not be required to achieve some of the observed beneficial  physiological effects of RSNOs.            
At present, reports on RSNO-modified materials as coatings for sensors and 
biomedical devices104-106 have been limited.  Frost and co-workers described the production  
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Figure 1.6. Common S-nitrosothiol decomposition pathways. 
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of photo-triggered NO-releasing films by encapsulating RSNO-modified silica particles in 
tri-layer polymer films.106  These films were capable of generating significant NO fluxes 
(≥1.7 pmol cm-2 s-1) for up to 12 h under bright illumination.  Although not yet demonstrated, 
the incorporation of RSNOs into xerogel films should be readily achieved in an analogous 
manner to NONOate-modified xerogels via the use of mercaptoalkoxysilane precursors.  
Hydrolysis and condensation of the thiol-terminated alkoxysilane precursors should allow the 
covalent binding of pendant thiol moieties into the siloxane backbone of the xerogel, which 
may be subsequently nitrosated via reaction with acidified nitrite.107  It is anticipated that 
these materials may provide a means of overcoming some of the short-comings of NONOate-
modified xerogels.  Charge-charge repulsion effects of RSNO-modifed films should be 
minimal compared to N-diazeniumdiolated films, leading to increased stability of the 
material in solution at greater NO donor loading conditions.  Thus enhanced NO flux and 
duration may be achievable.  The synthesis and characterization of RSNO-modifed xerogel 
films as an alternative strategy for creating NO-releasing xerogels was a second goal of my 
doctoral research.   
 
1.5. Nitroxyl Sensing via Aminoalkoxysilane Xerogels 
The dense, cross-linked nature of aminoalkoxysilane-derived xerogels need not 
always be viewed as problematic.  Despite the hinderance low permeability may present for 
the creation of certain sensors (e.g., NO-releasing glucose sensors), the same property may 
be beneficial for the fabrication of other sensors.  For example, Shin and co-workers used the 
low porosity of N-diazeniumdiolated AEMP3/MTMOS xerogels to fabricate an 
amperometric NO sensor with enhanced NO sensitivity compared to previously reported 
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sensors.108 Sensors fabricated with aminoalkoxysilane derived membranes showed ~106-fold 
increased selectivity for NO over nitrite, ascorbic acid, uric acid, and acetaminophen, 
common interfering species in biological environments.  Likewise, whereas the low oxygen 
permeability of aminoalkoxysilane-derived xerogels presented a problem for Marxer’s 
development of a NO-releasing amperometric oxygen sensor,85 the same property may be 
beneficial for applications where an anaerobic interior environment of the xerogel is desired. 
One application where decreased oxygen permeability may be a benefit is in the 
production of optical sensor membranes for the detection of nitroxyl (HNO), a one-electron-
reduced congener of NO.109  Despite their similarities, HNO’s chemistry and reactivity is 
distinct from NO,110-113 and the potential benefits of its pharmaceutical application are just 
beginning to be elucidated.114  For example, Pagliaro and co-workers demonstrated that 
exposure of cardiac muscle to HNO prior to ischemic injury, wherein the heart is deprived of 
oxygen for extended periods, decreased both tissue damage and infarct size and increased 
post-ischemic contractility.115  Similarly, Paolocci et al. examined the effects of HNO in dogs 
with failing hearts.116  Treatment with HNO resulted in both enhanced left ventricular 
contractility and selective venodilation, in effect making the heart beat more strongly without 
increasing its overall rate, a benefit that makes HNO a strong candidate for the treatment of 
congestive heart failure.  Nitroxyl has also been shown to be a key reactive product in the 
targeted inhibition of aldehyde dehydrogenase by the antialcoholism drug cyanamide,117, 118 
leading Nagasawa and co-workers to develop a series of HNO donors and prodrugs for the 
treatment of alcohol abuse.119-121  Such applications may be indicative of a general role for 
HNO in targeted enzyme inhibition through reaction with active-site thiol-terminated 
residues. 
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Despite the potential pharmaceutical benefits of HNO, research related to HNO 
chemistry and the development of HNO-donor compounds lags significantly behind that of 
NO.122, 123  Much of the difficulty of working with HNO lies in its high reactivity and 
problems associated with its detection.124  While highly specialized spectroscopic techniques 
may be used to detect HNO directly,125 generally, indirect means of screening for HNO (e.g., 
absorbance shifts associated with reductive nitrosylation of heme proteins)126 have been 
employed.  These absorbance techniques are generally non-quantitative as the resulting 
metal-NO complexes are unstable in the presence of oxygen.  By encapsulating HNO 
sensitive heme proteins (or their simplified porphyrin analogs127, 128) in the anaerobic interior 
of aminoalkoxysilane xerogel membranes, it may become possible to stabilize the 
nitrosylated complex and enable quantitative detection of HNO.  A third focus of my 
doctoral research involved the synthesis of HNO-sensing aminoalkoxysilane-derived xerogel 
films suitable for quantitative detection of HNO in an optical sensor format. 
 
1.6. Summary of Dissertation Research 
  My doctoral research has focused on maximizing the potential of sol-gel-derived 
materials for use in the creation of biomedical sensors and more biocompatible interfaces.  
This work has involved both modifying the core structure of the gel with new NO-donor 
functionalities to enhance the integration of sensors into surrounding blood and tissue, and 
also developing novel techniques and sensing platforms to best utilize the unique properties 
of previously developed aminoalkoxysilane-derived xerogel films.  The specific aims of my 
research included:   
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1) the design, fabrication, and characterization of a optical fiber-based NO-releasing 
pH sensor using NONOate-modified xerogel films; 
2) the evaluation of NO-release and antithrombogenic benefits achievable using 
NONOate-modifed xerogels in an optical sensor format; 
3) the synthesis of RSNO-modified films via nitrosation of mercaptoalkoxysilane-
derived xerogels; 
4) the evaluation of the NO-release capability, solution stability, and antibacterial 
and antithrombogenic properties of RSNO-modifed xerogels; 
5) the fabrication and characterization of aminoalkoxysilane-based HNO-sensing 
films for optical quantification of HNO; 
6) the optimization of HNO-sensing xerogel film properties for application in a 96-
well microtitre plate optical sensor format.       
 
The goal of Chapter 1 was to provide a brief overview of sol-gel chemistry and the 
versatility and benefits xerogels provide in sensor development.  Chapter 2 will focus on the 
fabrication of a NO-releasing optical pH sensor and the improvements in sensor response and 
NO release that can be achieved by using NONOate-modified xerogels in optical sensing 
formats versus previously described electrochemical designs.129  Chapter 3 focuses on the 
synthesis of novel RSNO-modifed xerogel coatings with improved stability and extended 
durations of NO generation compared to NONOate modified films.   Finally, Chapter 4 
discusses a novel application of aminoalkoxysilane-derived xerogels in the development of 
HNO-sensing optical films.130   
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Chapter 2: 
Nitric Oxide-Releasing Xerogel-Based Fiber-Optic pH Sensors 
 
2.1. Introduction 
Blood pH, when measured in conjunction with PCO2, provides a useful window into 
respiratory, cardiovascular, and renal function.1, 2  Strong shifts from arterial pH values of 7.4 
due to alkalosis and acidosis conditions are often indicative of respiratory or metabolic 
distress.  During thoracic surgeries and mechanical lung ventilation, blood gases (e.g., PO2, 
PCO2) and pH may fluctuate rapidly.3  Throughout these critical periods, the common 
clinical practice of periodic arterial blood sampling followed by bench-top laboratory blood 
gas analysis does not provide an adequately fast means of tracking respiratory function.  As 
such, real-time analysis strategies must be employed.  Techniques such as capnometry and 
transcutaneous blood gas measurement provide real-time detection, but have important 
limitations.  Capnometry requires normal pulmonary function to correctly estimate CO2 
concentration, which can lead to unreliable readings in critically-ill patients.3  
Transcutaneous sensors are often hampered by skin and tissue variations in adult subjects.4  
These issues may be circumvented by direct determination of blood gases through the 
implantation of miniaturized catheter sensors or sensor arrays into the arterial blood stream.  
To date, most intravascular blood gas sensors have been based on amperometric (e.g., 
Clark-style dissolved oxygen electrodes) or fiber-optic-based photochemical platforms.5  
Fiber-optic sensors may have greater appeal because of their high sensitivity, reduced 
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electrical interference, and ease of miniaturization for incorporation into bundled arrays. 6, 7  
Analyte concentrations are measured via their interaction with transducer dye molecules 
immobilized at the fiber surface, typically resulting in changes of absorbance or fluorescence 
intensity, lifetime, or phase.8  For example, the Paratrend 7+® (Diametrics Medical Inc.), a 
multiparameter continuous intravascular blood gas monitoring probe commercially available 
from 1999 to 2004, employed a bundle of three optical fiber probes modified to measure PO2 
via ruthenium dye fluorescence quenching, PCO2 and pH via phenol red absorbance, and 
temperature via a thermocouple.  Clinical trials confirmed that the real-time measurements 
made by these optical sensors compared well with intermittent laboratory blood gas analysis, 
the current clinical standard.3, 5, 9 
Despite favorable results in most cases, blood clot formation at the surface of fiber-
optic intravascular sensors has been reported.10, 11  Platelet adhesion and aggregation at a 
sensor limits analyte diffusion to the transduction element, rendering the sensor largely 
inoperable.12  At worst, subsequent dislodgement of the thrombus may lead to potentially 
serious health effects such as vessel occlusion.   Recent research has focused on the synthesis 
and characterization of nitric oxide (NO)-releasing polymers as antithrombogenic sensor 
membranes to combat blood clot formation.  Nitric oxide is released by human endothelial 
cells at femto- to picomolar fluxes where it helps regulate vasodilation and platelet 
activation.13  Indeed, polymers modified to release NO at physiological concentrations have 
demonstrated much lower proclivities for thrombus formation at a blood/material interface.14-
16  Unlike other systemically administered anticoagulants such as heparin, NO has a short 
half-life in blood (e.g., on the order of seconds), ensuring its antithrombogenic effects remain 
localized near the sensor/blood interface, precluding potentially detrimental side-effects.17  
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Nitric oxide release capability has been imparted to polymers through the inclusion of 
a number of NO donor functionalities, including nitrosothiols, nitrosamines, metal 
complexes, and diazeniumdiolates into the polymer via doping or covalent attachment.18  To 
date, nitrogen-bound diazeniumdiolates (N-diazeniumdiolates) represent the most widely 
employed NO donors for spontaneously generating NO from materials.  Briefly, N-
diazeniumdiolates are formed by exposing secondary amine precursors to high pressures of 
NO under basic conditions, resulting in the reversible binding of two NO molecules.  
Subsequent exposure to a proton source such as water initiates N-diazeniumdiolate 
decomposition and release of two equivalents of NO.19   Coatings utilizing this system have 
been employed to improve the biocompatibility of catheter and subcutaneous sensors for 
biologically relevant analytes.  Previously described examples include amperometric PO220, 
21 and glucose sensors,22 and potentiometric PCO2 sensors.23  Nitric oxide-releasing 
polymeric coatings suitable for fluorescence-based PO2 detection have also been reported, 
although miniaturized sensors were neither fabricated nor evaluated.24 
In this chapter, a NO-releasing optical fiber-based pH sensor was fabricated via sol-
gel chemistry.  During the sol-gel process, hydrolysis and condensation of silicon alkoxide 
precursors form a robust, glassy silica network referred to as a xerogel.25  Incorporation of 
aminoalkoxysilane precursors into the siloxane polymer backbone allows for the subsequent 
formation of covalently bound N-diazeniumdiolates, introducing NO-release capability to the 
xerogel.14, 26, 27  Nitric oxide-releasing xerogels with tunable NO-release kinetics have been 
reported previously, and their effectiveness in improving the biocompatibility of 
amperometric oxygen28 and glucose29, 30 sensors has been demonstrated.  Unfortunately, 
exposure of aminoalkoxysilane-based xerogels to high pressures of NO during N-
diazeniumdiolate formation was shown to accelerate sol-gel polycondensation, resulting in 
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dense (i.e., non-permeable) xerogel coatings.29  As such, sensors fabricated with such 
coatings often suffer from limited sensitivity and lengthened response times.  Strategies for 
overcoming the reduced analyte diffusion have included doping xerogel particles into 
conventional sensor membranes29 and utilizing soft-lithographic micropatterning techniques 
to selectively modify regions of the underlying electrode.30 While effective, these techniques 
make sensor fabrication more complicated and limit the overall flux of NO attainable at such 
surfaces. 
The dense nature of NO-releasing xerogel coatings may make them better suited to 
optical sensing platforms, where analyte diffusion to an electrode surface is not required.  
Optically transparent and chemically inert xerogels have long been recognized as a useful 
host matrix for fluorescent indicator molecules.31-33  The siloxane network properties 
including membrane porosity and permeability are easily manipulated by varying the 
composition of the sol (e.g., water:silane ratio and/or acid concentration). Furthermore, 
physical entrapment of indicator dyes in the gel is straightforward.  Herein, a miniaturized, 
NO-releasing xerogel-derived optical pH sensor suitable for intravascular use is described 
that combines the simplicity of sol-gel-based optical sensor fabrication with the added 
biocompatibility benefits of NO release. Using a two-layer immobilization strategy, xerogels 
containing both NO-producing N-diazeniumdiolates and the pH-sensitive fluorophore 
seminaphthorhodamine-1 carboxylate (SNARF-1) were immobilized onto optical fiber 
supports. The fabrication, analytical performance, and enhanced blood biocompatibility of 
the NO-releasing optical pH sensors are discussed.  
 
 43
2.2. Materials and Methods 
Ethyltrimethoxysilane (ETMOS), isobutyltrimethoxysilane (BTMOS) 
methyltrimethoxysilane (MTMOS), (aminoethylaminomethyl)phenethyltrimethoxysilane 
(AEMP3), N-(6-aminohexyl)aminopropyltrimethoxysilane (AHAP3), and 
aminopropyltriethoxysilane (APTES), and  were purchased from Gelest (Tullytown, PA). 
Tetramethyl orthosilicate (TMOS), glutaraldehyde (50% w:w in water), and 
hexamethyldisilazane (HMDS) were purchased from Aldrich (Milwaukee, WI).   
Seminaphthorhodamine-1 carboxylate (SNARF-1) pH indicator was purchased from 
Invitrogen (Carlsbad, CA).  Nitric oxide (99.5%) was purchased from National Welders 
Supply (Durham, NC).  Whole blood was obtained from healthy pigs at the Francis Owen 
Blood Research Laboratory (Chapel Hill, NC). Other solvents and chemicals were analytical-
reagent grade and used as received. Distilled water was purified to 18.2 MΩ·cm with a 
Millipore Milli-Q Gradient A-10 water purification system (Bedford, MA).  Optical fiber 
materials were purchased from Ocean Optics (Dunedin, FL). 
 
2.2.1. NO-releasing Xerogel Preparation 
Nitric oxide-releasing xerogels were prepared through the inclusion of 20 or 40% 
AHAP3 in ETMOS gels (v:v total silane).  Ethanol (300 µL) was mixed with ETMOS (160 
or 120 µL) and AHAP3 (40 or 80 µL) in a vortex shaker for 5 min.  Water (10 µL) was 
added and shaken for an additional 5 min.  The sol was then immobilized on optical fibers 
via dip-coating or drop-cast onto glass slides.  
 
2.2.2. pH-Sensing Xerogel Preparation 
Xerogels containing the SNARF-1 pH indicator were fabricated in a manner similar 
to that described by Grant and Glass.34  Water (1000 µL) was combined with TMOS (500 
 44
µL) and 0.04 M HCl (10 µL) and sonicated in an ice bath.  After 30 min, a 75 µL aliquot of 
the sol was combined with 20 µL of a 5 mM SNARF-1/water stock solution and diluted with 
300 µL pH 7.4 phosphate buffered saline (PBS).  The sol was sonicated on ice for an 
additional minute prior to dip-coating procedures. 
 
2.2.3. Sensor Fabrication 
 Two-layer NO-releasing pH sensors were created by sequential dip-coating of optical 
fibers in the AHAP3/ETMOS and TMOS sols.  Unjacketed silica core/silica clad optical 
fiber (400 µm o.d., NA = 0.22) was cut into 8 cm segments and the polyimide sheathing 
around the fiber was removed by immersion in hot concentrated sulfuric acid.  The fibers 
were tapered to enhance the coupling of fluorescent modes into the fiber core.35  
Approximately 1.0 cm of the bare silica fiber was immersed in a concentrated hydrofluoric 
acid bath with an overlying layer of toluene for 2.5 h,36 resulting in the self-terminated 
tapering of approximately 0.5 cm of the distal end of the fiber down to 80 µm o.d.  After 
rinsing, 2 cm of the tapered optical fibers were manually dip coated twice into the 
AHAP3/ETMOS sol, drying 1 min in a 75 °C oven between coats.  Sensors were allowed to 
age for a minimum of 3 d under ambient conditions before 1 coat of the pH-sensing sol was 
applied in a similar manner.  Again, sensors were aged for a minimum of 3 d under ambient 
conditions before N-diazeniumdiolate formation.  Sensors were placed in an in-house 
reaction vessel and thoroughly flushed with Ar prior to exposure to 5 atm NO for 3 d.  
Unreacted NO was subsequently removed, and sensors were stored at -20 °C until use. 
 
2.2.4. Apparatus 
Sensors were evaluated with a simple optical fiber-based spectrophotometer system. 
The xerogel-coated probes were coupled directly to the common leg bundle of a solarization 
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resistant 200 µm o.d. bifurcated optical fiber assembly via an SMA905 connector and Ocean 
Optics SMA905 bare fiber adaptor.  Excitation light was supplied through one leg of the 
bifurcated assembly by a Power Technology Inc. LDCU3/3663 10 mW, 532 nm laser 
(Alexander, AR) after passing through a 90% attenuation neutral density filter.  Fluorescent 
emission from the xerogel coating was coupled back into the probe and partially transmitted 
through the second leg of the bifurcated assembly for detection at an Ocean Optics USB2000 
Spectrometer.  Sensor response characteristics were determined by sequential immersion of 
the probes in PBS solutions buffered across the common physiological pH range of blood 
(pH 7.0-7.8).  Complete spectra in the 400-800 nm range were generated and saved with 
Ocean Optics OOIBase32 software.  Fluorescence intensities at the 580 and 640 nm peak 
emission wavelengths of the SNARF-1 pH indicator, were later extracted and ratios 
generated using LabVIEWTM (National Instruments). 
 
2.2.5. Characterization of NO Release 
Real-time NO flux from AHAP/ETMOS xerogels prepared with and without TMOS 
overlayers was monitored using a Sievers NOATM 280 Chemiluminescence Nitric Oxide 
Analyzer (Boulder, CO).  Xerogel films were cast onto glass slides via glutaraldehyde 
fixation procedures.  The slides were cleaned in 10% nitric acid (v:v, water) at 70 °C for 30 
min, rinsed with purified water, immersed in 10% APTES (v:v, PBS, pH 7.0) at 70 °C for 90 
min, rinsed again, and then immersed in 10% glutaraldehyde (v:v, water) at 25 °C for 60 
min.  After rinsing the slides thoroughly with water, AHAP3/ETMOS gel solution (30 µL) 
was drop-cast onto the slides and allowed to dry under ambient conditions.  After drying for 
24 h, a TMOS overlayer was dip-coated over select gels by complete immersion of the 
xerogel-coated glass slides in the TMOS sol.  Dip-coated gels were allowed to dry for an
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additional 3 days under ambient conditions. The resulting xerogel films were then exposed to 
5 atm NO for 3 d to form N-diazeniumdiolates as described above and stored at -20 °C until 
use.  The Sievers NOA 280 instrument was calibrated before each experiment using air 
passed through a Sievers zero NO filter and 24.1 ppm NO gas (balance N2).  Individual slides 
were immersed in 20 mL PBS buffer (pH 7.4) at 37 °C and sparged with a 200 mL/min N2 
stream.  Detected chemiluminescence due to NO was monitored continuously in 1 sec 
intervals for 16 h.   
 
2.2.6. Platelet Adhesion Studies 
Healthy porcine blood was drawn into acid citrate dextrose (ACD)-anticoagulated 
tubes (1 part ACD to 9 parts whole blood) and maintained at 37 °C for 1 h prior to use.  
Platelet enriched plasma (PRP) was obtained by centrifugation at 150g for 20 min at room 
temperature.37  Normal platelet activity was reestablished by the addition of CaCl2 to achieve 
a 0.5mM Ca2+ concentration.  Individual NO-releasing xerogel films (prepared as described 
above) and controls were immersed in 2 mL PRP at 37 °C for 1 h.  Loose platelets and cells 
were removed by rinsing with 37 °C Tyrodes buffer (137 mM NaCl, 2.7 mM KCl, 3.3 mM 
KH2PO4, 5.6 mM glucose, pH 7.35).  The remaining adhered platelets were fixed by 
immersing the slides in a 1% glutaraldehyde solution (v:v, Tyrodes buffer) at 37 °C for 30 
min.  The slides were rinsed with Tyrodes buffer and water, and chemically dried as follows 
to preserve cell morphology.  Slides were immersed in 50, 75, and 95% ethanol (v:v, water) 
for 5 min, 100% ethanol for 10 min, and HMDS overnight.  Representative scanning electron 
microscope (SEM) images of all samples were obtained.  Semiquantitative platelet surface 
coverages on NO-releasing samples were calculated via digital image processing and 
black/white thresholding from phase contrast images obtained with a Zeiss Axiovert 200 
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inverted microscope (Chester, VA). Average percent surface coverages were calculated from 
the overall average of five slides, with 5 images taken per slide. 
 
2.3. Results and Discussion 
The near-neutral dynamic range (pKa = 7.5) and useful dual emission properties of 
the SNARF-1 fluorescent pH indicator make it an attractive choice for intravascular pH 
sensing.38  Both acid and base isomers fluoresce strongly at 580 and 640 nm, respectively, 
and may be excited at a single wavelength. By monitoring the ratio of the fluorescent 
intensity at two emission maxima instead of intensity changes at only one wavelength, the 
dye provides a self-referencing means to compensate for common sources of signal drift such 
as photobleaching and light source inconsistencies.  Fabrication of NO-releasing optical pH 
sensors was first attempted by direct encapsulation of SNARF-1 indicator within several 
aminoalkoxysilane/alkoxysilane systems, including AEMP3/MTMOS, AHAP3/ETMOS, and 
AHAP3/BTMOS xerogels.  Unfortunately, sensors fabricated by direct SNARF-1 
encapsulation in the aminoalkoxysilanes-modified xerogels proved unresponsive.. No 
changes in fluorescent emmision were observed when such sensors were immersed in PBS of 
pH 7.0 - 7.8 (data not shown).  The lack of response can be explained by the nature of the 
aminoalkoxysilane xerogels used to host the SNARF-1 indicator.  Stable, NO-releasing 
xerogels require aminosilane precursors in conjunction with more inert ethyl- or methyl-
substituted alkoxysilanes. 14  Such xerogel networks are inherently more hydrophobic than 
those formed strictly from inorganic silanes like tetramethyl and tetraethyl orthosilicates.39  
Additionally, when exposed to high pressures of NO to form N-diazeniumdiolates, 
aminoalkoxysilane xerogels suffer an extreme loss of permeability.29  As such, it is unlikely 
that buffer was penetrating into the bulk of the xerogel and thus, the majority of the 
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fluorescent emission measured did not reflect the pH conditions of the surrounding buffer but 
rather the static interior pH of the bulk xerogel matrix. 
 
2.3.1. Two-Layer Sensors 
To improve the responsiveness of the NO-releasing optical pH sensors, a benefit of 
optical sensing platforms was utilized.  Unlike amperometric sensors, fiber-optic sensors do 
not require that the analyte permeate through a polymeric membrane to an electrode. As long 
as fluorescent emission from the pH indicator is coupled back into the optical fiber, the 
indicator may be separated physically from the fiber surface.  While xerogels modified with 
N-diazeniumdiolates suffer from low analyte permeability, they remain optically transparent. 
Thus, the application of a thin, NO-releasing xerogel directly to a fiber-optic surface will 
present minimal interference to the coupling of excitation and emission modes to and from 
an overlying xerogel layer encapsulating the pH indicator.  Two-layer NO-releasing optodes 
comprised of a 40:60% (v:v) AHAP3/ETMOS NO-releasing xerogel as a base layer and a 
TMOS xerogel overlayer doped with the SNARF-1 indicator showed a significantly 
improved response (i.e., change in fluorescent emission at 580 and 640 nm) to buffer pH 
compared to single-layer sensors (Figure 2.1). 
 
2.3.2. Sensitivity and Reproducibility 
The response of the two-layer NO-releasing sensors was measured by sequential 
immersion of the optical fiber in PBS solutions buffered between pH 7.0 and 7.8 (Figure 
2.2).  The response of the sensors was linear (R2 ≥ 0.986) throughout the tested pH range.  
From the calibration curves generated, a minimum resolvable pH shift of approximately 0.04 
pH units was estimated by doubling the average standard deviation of emission ratios at 
individual pH values.  The sensitivity and signal reproducibility of five individual sensors, as
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Figure 2.1. Fluorescence emission spectra from a 40:60% (v:v) AHAP3/ETMOS-
TMOS optical pH sensor immersed in phosphate buffered saline at pH 
(A) 7.0; (B) 7.4; and (C) 7.8. 
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Figure 2.2. Time-resolved response from 40:60% (v:v) AHAP3/ETMOS-TMOS 
optical pH sensor immersed in pH 7.0-7.8 PBS solutions. 
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well as the average emission ratio of each sensor at pH 7.4, are provided in Table 2.1.  As 
expected, variation between sensors was apparent.  Such variability is attributed to 
inconsistencies in fiber tapering and coating.  The TMOS gel employed for SNARF-1 
encapsulation reacts and solidifies rapidly.  Thus, a natural evolution of the gelation can be 
observed during the dip coating procedure. The sol coated onto fibers later in succession is 
generally more viscous, resulting in the deposition of a thicker xerogel layer.40  While more 
stringent timing control and automated dip-coating procedures would likely reduce sensor-to-
sensor variations, calibration of individual sensors prior to use is still necessary. 
 
2.3.3. Pretreatment and Response Time 
A common concern reported for xerogel-based sensors employed in aqueous solution 
is lengthy response times, which can range from seconds up to hours.41-46 While porosity and 
gel hydrophobicity play an important role in determining diffusion rates through the material, 
Ismail et al. have demonstrated that hydrogen bonding at the gel/liquid interface has an 
equal, if not greater effect in many cases.47  Xerogels may contain a large number of 
unreacted free silanol groups capable of forming hydrogen bonds with other nearby free 
silanols either directly or through the mediation of bridging water molecules.  These 
hydrogen bond networks can serve as a barrier to rapid equilibrium of the exterior aqueous 
environment with the interior of the xerogel.  Proton-exchange indicator molecules trapped 
in the xerogel can associate with residual protons and water molecules retained by hydrogen 
bonding until complete equilibrium of the material with its surrounding environment is 
achieved.  The result is long response times and lengthy soaking requirements of xerogel-
based sensors prior to use.   Obviously, long response times are less than optimal for most 
sensing applications. Long presoak requirements are especially detrimental for sensors 
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Sensor 580 / 640 nm 
Emission Ratio a 
∆ Emission 
Ratio / ∆ pH
R2 Average standard  
deviation 
Resolvable 
pH Shift 
1 0.850 0.196 0.986 0.00392 0.040 
2 0.589 0.113 0.999 0.00203 0.036 
3 0.707 0.116 0.999 0.00173 0.030 
4 0.502 0.075 0.999 0.00138 0.037 
5 0.581 0.079 0.998 0.00173 0.044 
           a pH = 7.4 
Table 2.1. Reference emission ratios, sensitivity, linearity, and signal 
reproducibility of 40:60% (v:v) AHAP3/ETMOS-TMOS NO-releasing 
sensors.   
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modified with NO-releasing coatings as NO release is initiated from diazeniumdiolate NO 
donors upon solution immersion.  For NO-releasing xerogel based amperometric oxygen 
sensors, Marxer et al. was able to reduce the minimum presoaking time to 30 min (to obtain 
adequate sensitivity) by increasing the permeability of the xerogel via the inclusion of 1% 
(v:v) hydrophilic polyurethane in the gel.28 Doping xerogel coatings to be used for optical 
sensors with such polymers, however, would lead to optically opaque films. 
To ensure rapid response with minimal presoak requirements, the xerogel optical 
sensors were immersed in 0.5 M sodium hydroxide solution for 30 s prior to use, as 
described previously by Ismail et al.47  Brief exposure to strongly basic solution allowed for 
rapid disruption of the silanol hydrogen bond networks present and substitution by sodium 
cations while having minimal effect on the proton-induced decomposition of N-
diazeniumdiolates.  The encapsulated SNARF-1 indicator was thus free to equilibrate with 
the surrounding buffer.  The brief immersion in base may also serve to break siloxane bonds, 
further opening up the xerogel for more rapid analyte diffusion throughout the material. Such 
polymer breakdown was limited, however, as successive base immersions did not lead to 
changes in response or further reductions in fluorescent signal intensity.  Following base 
immersion, the sensors were immediately used to monitor pH.  Sensor response times were 
determined by tracking the shift of fluorescent emission ratios in 0.9 s increments as the two-
layer sensor was moved from pH 7.8 to pH 7.0 buffer solutions.  The time required to 
achieve 90% of the final response (τ90) was determined by fitting the resulting data to a first 
order exponential decay model (Figure 2.3).  The 40:60% (v:v) AHAP3/ETMOS-TMOS 
modified sensors exhibited extremely rapid response characteristics, with a calculated 
average τ90 of 14 ± 2 s (n = 3).  Indicator leaching after base immersion was evaluated by 
monitoring the average intensity of 640 nm SNARF-1 fluorescence at hourly intervals from
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Figure 2.3. Timed response of 40:60% (v:v) AHAP3/ETMOS-TMOS optical pH 
sensor as a function of pH (7.0-7.8). 
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a sensor immersed in pH 7.4 PBS.  Over the course of 20 h, the fluorescence intensity 
measured at 640 nm did not change (1070.1 ± 5.3 and 1068.0 ± 9.5 a.u. at 0 and 20 h, 
respectively).  Thus, the AHAP3/ETMOS-TMOS coatings allowed immediate sensor use and 
rapid response with only a 30 s base pretreatment step. 
 
2.3.4. Nitric Oxide Release 
Manipulation of the identity and percentage of aminosilane employed in the original 
sol mixture allows control over the magnitude and duration of NO released by a N-
diazeniumdiolate-modified xerogel film.27  To evaluate the NO-release potential of the two-
layer AHAP3/ETMOS-TMOS coatings employed in this study, real-time NO flux 
measurements were performed via chemiluminescence.  Example NO release profiles 
demonstrating the NO flux generated by coatings comprised of 20 and 40% AHAP3 (v:v; 
balance ETMOS) are shown in Figure 2.4.  The optimal NO flux for reducing thrombus 
formation at a blood/material interface is generally believed to fluctuate depending on the 
localized abundance of NO-scavengers (e.g., proteins, thiols, etc.) in the surrounding 
environment.  Ramamurthi and Lewis have reported that surface NO fluxes as low as 0.6 
fmol/cm2s were effective at reducing in vitro platelet adhesion.48  Likewise, Robbins et al. 
demonstrated maintained thromboresistivity for up to 24 h at micropatterned xerogel arrays 
with NO surface fluxes of 0.4 pmol cm-2 s-1.49  Considering 0.4 pmol cm-2 s-1 as a minimum 
threshold value for inhibiting platelet adhesion, sensors fabricated with 20% AHAP3 would 
be thromboresistant for approximately 6 h.  Likewise, sensors prepared with 40% AHAP3 
xerogels would maintain fluxes > 0.4 pmol cm-2 s-1 for at least 16 h.  Notably, the addition of 
a TMOS overlayer to the NO-releasing AHAP3/ETMOS films prior to N-diazeniumdiolate 
formation did not alter the NO-release profile significantly (Figure 2.4), suggesting that the
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Figure 2.4. Nitric oxide release from (A) 40:60% and (B) 20:80% (v:v) 
AHAP3/ETMOS xerogels; and, (C) 20:80% (v:v) AHAP3/ETMOS 
xerogel with a TMOS overlayer film, immersed in 37 °C PBS (pH 7.4). 
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presence of the porous pH-sensing TMOS layer does not serve as an impediment to NO or 
proton transport through the gel. 
 
2.3.5. In vitro Platelet Adhesion Studies 
Platelet adhesion to slides coated with NO-releasing AHAP3/ETMOS (40:60%, v:v) 
xerogels with and without a TMOS overlayer was examined to evaluate the potential blood 
compatibility of the xerogel coatings. Representative scanning electron micrographs of 
platelet adhesion to the films are shown in Figure 2.5. After 1 h exposure to platelet enriched 
porcine plasma, platelet adhesion at both the single and two-layer NO-releasing films was 
significantly decreased compared to non-NO-releasing controls. As expected, NO contributes 
a strongly inhibitory effect on platelet adhesion, resulting in drastic reductions in overall 
coverage of platelets at xerogel coatings. As suggested by NO-flux measurements, the 
presence of the TMOS overcoat layer did not inhibit the effectiveness of the underlying NO-
releasing film.  In fact, TMOS-coated films showed slightly less platelet adhesion than 
AHAP3/ETMOS films (5.7 ± 1.5 versus 2.0 ± 0.9 percent coverage, respectively).  
Intravascular fiber optic pH sensors may be expected to exhibit similar biocompatibility 
benefits in vivo throughout the window of NO-release. 
 
2.4. Conclusions   
Introducing NO-release capability to a device implanted in the bloodstream may 
allow for significant reductions in platelet adhesion and thrombus formation at the material’s 
surface and a concomitant improvement in the device’s performance. For sensors, xerogel 
coatings modified with N-diazeniumdiolates provide a useful means of generating such NO 
release.  To avoid the issue of low permeability observed for NO-releasing xerogel 
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Figure 2.5. Representative scanning electron micrographs illustrating platelet 
adhesion to (A) NO-releasing and (C) control 40:60% (v:v) 
AHAP3/ETMOS films, and equivalent (B) NO-releasing and (D) 
control films with TMOS overcoats. 
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amperometric sensors, an optical sensing strategy was employed.  Through straightforward 
dip-coating procedures, two-layer NO-releasing pH optical sensors were fabricated by 
depositing a porous pH-sensing xerogel layer over AHAP3/ETMOS NO-releasing xerogel-
coated optical fibers. Sufficient resolution and response times were obtained from the 
resulting pH sensors after only a 30 s pretreatment step in sodium hydroxide solution. In 
vitro platelet adhesion studies indicated that the flux of NO (>0.4 pmol cm-2 s-1 for 16 h) from 
the xerogel coatings was effective at reducing platelet adhesion. It is anticipated that the pH 
sensors and techniques described herein may be utilized in the fabrication of more 
biocompatible elements for intravascular blood gas sensor arrays and as the basic 
transduction mechanism for physiologically relevant chemical (e.g., CO2, NH4+) and enzyme-
based (e.g., glucose, urea) biosensors.50 
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Chapter 3: 
Preparation and Characterization of S-Nitrosothiol (RSNO)-Modified Xerogels 
 
3.1. Introduction 
A number of problems continue to hinder the biocompatibility of indwelling medical 
devices.  Biofouling of implanted materials, such as surface-induced aggregation of adhesion 
proteins and platelets and onto intravascular stents and sensors, lead to significant functional 
impairment of device operation and potentially disastrous health effects such as vessel 
occlusion.1, 2  Even in the absence of thrombus formation, the foreign body response results 
in the sequestration of tissue-implanted biomaterials within a dense avascular collagen 
capsule, thereby limiting interaction of the device with the surrounding environment.3, 4  All 
implanted materials also carry with them bacteria and the risk of implant-associated 
infection.  Alarmingly, indwelling medical devices are responsible for >1,000,000 hospital-
acquired infections per year in the U.S. alone.5   
Clearly, methods to increase material biocompatibility and reduce the threat of 
implant-associated infection are drastically needed.  The integral role of nitric oxide (NO) in 
the  physiological processes governing platelet activation, angiogenesis, and the phagocytotic 
response to microbial infection make NO uniquely qualified as a potentially universal means 
to overcome problems associated with medical implants.  Nitric oxide-releasing polymeric 
coatings have proven to be an effective strategy for reducing the body’s response to foreign 
materials and improving the integration of biomedical devices into surrounding blood and 
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tissue.6-8   Polymeric materials are most often modified to release NO through physical 
entrapment or covalent attachment of NO-donor functionalities such as nitrosamines, metal 
complexes, S-nitrosothiols, or N-diazeniumdiolates.9  Nitrogen-bound diazeniumdiolates 
(NONOates) have been the most widely studied of these NO-donors.9  Several NO-releasing 
biomedical coatings and sensors with demonstrated antithrombotic and antibacterial effects 
have been fabricated through incorporation of NONOate donors in polymeric materials.6, 8, 9  
Though a convenient and efficient means of generating NO, NONOates are not without 
drawbacks. Controlling the flux of NO from these materials can be difficult.  NO generation 
is highly pH dependent, and strategies for overcoming localized elevated pH due to 
regeneration of parent amines upon NONOate decomposition are required to maintain high 
NO fluxes.10  The inclusion of high concentrations of amines in N-diazeniumdiolated 
materials may also have undesirable cytotoxic effects on nearby tissue.  For example, Nablo 
et al. reported a high instance of cell death among L929 mouse fibroblasts directly contacting 
amine-modifed xerogel materials.11  Cytotoxicity was partially alleviated upon modification 
of the amines to NONOate donors, indicating the amines, not NO, were the root cause of the 
cytotoxicity. 
Though not as widely studied as NONOate-based coatings, S-nitrosothiols (RSNOs) 
provide an appealing alternative for providing NO-release capability to a material.  Created 
via the reaction of thiols with reactive nitrogen oxide species (e.g., N2O3, HNO2), RSNOs 
formed on free thiols (e.g., S-nitrosoglutathione; GSNO) and cysteine residues of blood 
proteins (e.g., serum albumin) are speculated to function as the body’s reservoir and means 
of transporting the short-lived NO free radical throughout the bloodstream.12, 13  Small 
molecule RSNOs such as S-nitroso-N-acetyl-L-cysteine (SNAC) have been studied widely as 
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NO delivery agents, and the solution phase antimicrobial14, 15 and antithrombotic16-18 effects 
of RSNO NO donors have been well characterized.  Nitric oxide release from RSNOs may be 
inititated through a number of trigger mechanisms, including thermal and light-initiated 
homolytic cleavage of the S-N bond,19 catalytic reaction with Cu+,20 or reaction with other 
thiols through a nitroxyl (HNO) intermediate.21  As a mimic of physiological NO transport in 
the body, toxicity concerns due to side-product formation or regeneration of the parent thiol 
upon RSNO decomposition are minimal compared to NONOate donors, which are known to 
form potentially toxic nitrosamines upon recombination with NO-oxidation reaction 
intermediates.22 
Despite the potential benefits of RSNOs, relatively few reports of RSNO-modified 
polymeric coatings for NO generation exist.  Bohl and West reported the formation of S-
nitrosocysteine-modified polyethylene glycol (PEG) hydrogels.23  The hydrogels were 
capable of generating NO for short periods (4-12 h) and reduced smooth muscle cell 
adhesion on sections of angioplasty-damaged arteries in rat models.24  A number of NO-
releasing polymers were reported by de Oliveira and co-workers wherein small molecule 
RSNOs such as SNAC and S-nitrosoglutathione (GSNO) were dispersed in PEG or solid 
poly(vinyl alcohol)/poly(vinyl pyrrolidone) films.25-28  However, NO delivery was 
accomplished in these cases by rapid physical leaching of the hydrophilic small-molecule 
RSNO out of the polymer matrix into the soak media, making the materials of limited use as 
implant coatings.  Photoswitchable NO-generating materials have been described by Frost 
and co-workers through the incorporation of RSNO-modifed fumed silica particles in the 
central region of tri-layer polymer films.29  Such films generated detectable NO fluxes only 
under bright illumination and were capable of maintaining NO fluxes ≥1.7 pmol cm-2 s-1 for 
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nearly 12 h with 40 W illumination.  Seabra et al. reported polynitrosated polyesters with 
covalently attached RSNO functionalities capable of high initial rates of NO release (475 
µmol g-1 h-1 for 2 h) at physiological temperature.30  The polyester macromolecules did not 
form solid films, but remained water-insoluble liquids best suited for transdermal NO 
delivery. 
In this chapter, a novel class of polymeric S-nitrosothiol films, RSNO-modifed 
xerogels, is evaluated as a new type of NO-releasing material for use in the production of 
more biocompatible medical implant devices.  Xerogels are sol-gel derived polymeric 
materials formed through the catalytic hydrolysis and condensation of alkoxy-terminated 
silane precursors.31  Previous studies have examined NONOate-modified xerogel films as a 
means of imparting NO-release capability to biomedical sensors and devices.  Unfortunately, 
these materials have suffered from relatively short durations of NO production under 
physiological conditions and may exhibit undesireable cytotoxicity due to high 
concentrations of surface amines.11  In the present work, the production of RSNO-modified 
films formed via nitrosation of mercaptoalkoxysilane-derived xerogels is described.  The 
stability and NO-release properties of RSNO-modifed xerogels are characterized, and the 
resistance of the films to platelet and bacterial adhesion are examined and compared to 
previously described NONOate-based NO-releasing materials.  
 
3.2. Materials and Methods 
 
Mercaptopropyltrimethoxysilane (MPTMS), ethyltrimethoxysilane (ETMOS), and 
isobutyltrimethoxysilane (BTMOS) were purchased from Gelest (Tullytown, PA). 
Methyltrimethoxysilane (MTMOS) and diethylenetriamine-pentaacetic acid (DTPA) were 
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purchased from Fluka. Glutaraldehyde (50% w:w in water), hexamethyldisilazane (HMDS), 
and L-glutathione (reduced) were purchased from Aldrich (Milwaukee, WI). Pseudomonas 
aeruginosa (ATCC #19143) was obtained from American Type Culture Collection 
(Manassas, VA).  Nitric oxide calibration gas (27.6 ppm; balance N2) was purchased from 
National Welders Supply Co. (Durham, NC).  Whole blood was obtained from healthy pigs 
at the Francis Owen Blood Research Laboratory (Chapel Hill, NC). Other solvents and 
chemicals were analytical-reagent grade and used as received. Distilled water was purified to 
18.2 MΩ·cm with a Millipore Milli-Q Gradient A-10 water purification system (Bedford, 
MA). 
 
3.2.1. Xerogel Film Synthesis  
Sols containing 20-80% (v:v total silane) MPTMS (balance MTMOS) were created 
by shaking ethanol (800 µL),  MTMOS (160-640 µL), MPTMS (640-160µL;  total silane 
volume =  800 µL), and 0.5 mM HCl (25 µl) for 1 h.  Sols were allowed to age under 
ambient conditions for an additional 0-6 h, and 30 µl aliquots were cast onto 9 x 25 mm2 
glass substrates previously sonicated 20 min in ethanol, dried under N2, and UV/O3 cleaned 
for 20 min in a BioForce TipCleaner (Ames, IA).  Films were allowed to dry at room 
temperature overnight, and transferred to a 70 °C oven for 1-2 d.   
 
3.2.2.   Nitrosothiol Formation   
Pendant thiols of MPTMS/MTMOS xerogels were nitrosated by reaction with 
acidified nitrite.32  Films were protected from light and incubated for fixed intervals in 2 mL 
0.5 M HCl containing a 10-fold molar excess of NaNO2 (vs. moles thiol) and 100 µM DTPA.  
The xerogels were washed 3 times with 100 µM DTPA(aq)  and stored in the dark at -20 °C 
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until use.  Spectral characterization of RSNO formation was performed by affixing the slides 
normal to the light path of a PerkinElmer Lamba 40 UV/Vis Spectrophotometer (Norwalk, 
CT) in cuvettes containing 2 mL phosphate buffered saline (PBS; 10mM phosphate, pH 7.4).  
Characteristic RSNO absorbance bands (330-350 nm; n0→π* and 550-600 nm; nN→π*)33, 34 
were monitored as a function of nitrosation reaction time and percentage mercaptosilane in 
the xerogel. 
 
3.2.3. Characterization of NO Release 
Real-time NO release from RSNO-modifed xerogels was monitored using a Sievers 
NOATM 280 Chemiluminescence Nitric Oxide Analyzer (Boulder, CO).  Calibration of the 
instrument was performed daily using air passed through a Sievers NO zero filter and 27.6 
ppm NO gas (balance N2).  Individual slides were immersed in 30 mL pH 7.4 PBS containing 
100 µM DTPA and sparged with a 200 mL/min N2 stream.  Temperature control was 
achieved by immersing the sample flask in a water bath maintained between 0 and 37 °C. 
Chemiluminescence due to NO was monitored continuously in 1 s intervals.  Thiol-intiated 
RSNO decomposition was monitored by the inclusion of 500 µM glutathione (GSH). 
 
3.2.4. Xerogel Film Stability  
Nitrosated xerogel films on glass slides (N = 5) were immersed in 10 mL pH 7.4 PBS 
and incubated at 37 °C. Films were removed and transferred to fresh solutions of PBS at 
fixed intervals.  Leached Si concentrations in the PBS soak solutions were determined using 
a direct current plasma optical emission spectrometer (DCP-OES; ARL-Fisons Spectraspan 
7; Beverly, MA) calibrated with 0–50 ppm Si standard solutions in PBS. 
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3.2.5. Bacterial Adhesion to RSNO Xerogels 
 
 P. aeruginosa was cultured at 37 ºC in tryptic soy broth (TSB), pelleted by 
centrifugation, resuspended in 15% glycerol (v:v in PBS), and stored at -80 ºC. Cultures for 
bacterial adhesion studies were grown from a -80 ºC stock in 37 ºC TSB overnight.  A 1 mL 
aliquot of overnight culture was inoculated into 100 mL fresh TSB, incubated at 37 ºC with 
rotation, and grown to a concentration of ~108 colony-forming units (cfu)/mL (verified by 
10-fold serial dilutions in PBS, plating on tryptic soy agar nutrient plates, and subsequent cfu 
enumeration). The bacteria were pelleted by centrifugation, rinsed with ultrapure water, and 
resuspended in sterile PBS.  Control and RSNO-modified xerogels were immersed in 4-mL 
aliquots of bacterial suspension and incubated at 37 ºC.  After 1 h, the xerogel substrates 
were removed from the bacterial suspension, gently immersed in ultrapure water to remove 
loosely-adhered cells, and gently dried under a stream of N2.  To quantify bacterial adhesion, 
substrates were imaged in phase-contrast mode with a Zeiss Axiovert 200 inverted optical 
microscope (Chester, VA) at 20x magnification.  Digital micrographs were captured with a 
Zeiss Axiocam digital camera (Chester, VA).  To determine the percent surface coverage of 
bacteria, each image was digitally processed by applying a threshold value to differentiate 
adhered cells from the background.  The number of pixels corresponding to adhered bacterial 
cells was digitally enumerated and the extent of bacterial adhesion reported as the percent of 
the xerogel substrate surface covered with bacterial cells.  For the time-based adhesion 
studies 60% MPTMS xerogels were incubated in PBS supplemented with 500 µM GSH for 
24 h prior to the 1 h adhesion experiment described above. 
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3.2.6. Platelet Adhesion to RSNO Xerogels  
 
Healthy porcine blood was drawn into acid citrate dextrose (ACD)-anticoagulated 
tubes (7:60 v:v, ACD:whole blood) and maintained in ambient conditions up to 30 min 
before use.  Platelet enriched plasma (PRP) was obtained by centrifugation at 400g for 20 
min at room temperature.35  Normal platelet activity was reestablished by incubation with 2.0 
mM CaCl2 · 2H2O at 37 ºC for 5 min.  Nitrosated xerogel films and controls were incubated 
in 2 mL PRP at 37 °C for 1 h.  The PRP was carefully removed and the slides were washed 
thrice with 37 ºC Tyrodes Buffer (137 mM NaCl, 2.7 mM KCl, 5.6 mM glucose, 3.3 mM 
KCl, pH 7.35). Adhered platelets were fixed by incubating with 1% glutaraldehyde solution 
(v:v, Tyrodes buffer) at 37 ºC for 30 min. The films were rinsed with Tyrodes buffer and 
immersed twice in fresh Tyrodes buffer and once in Milli-Q water to minimize remaining 
non-adherent cells. To preserve cell morphology, the slides were chemically dried by 
exposure to 50, 75, and 95 and 100% ethanol (v:v, water) for 5 min.  Phase-contrast images 
of adhered platelets were obtained at 20x magnification.  Percent platelet surface coverages 
on nitrosated xerogels and controls were calculated via digital image processing and 
black/white thresholding as described above. 
 
3.3. Results and Discussion 
 
 
3.3.1. Xerogel Characterization 
 
The relative ease of xerogel modification through variation of alkoxysilane precursors 
makes sol-gel chemistry a convenient scaffold for the production of NO-releasing materials 
and a versatile material for use in biomedical sensors and devices.  In these experiments, sols 
were created using mercaptopropylthrimethoxysilane (MPTMS), a commercially available 
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thiol-terminated alkoxysilane, in conjunction with three alkylalkoxysilanes: 
methyltrimethoxysilane (MTMOS), ethyltrimethoxysilane (ETMOS), and 
isobutyltrimethoxysilane (BTMOS).  The structures of these molecules are illustrated Figure 
3.1.  Incorporation of alkylalkoxysilanes as an inert polymer backbone material allows 
control over the NO fluxes generated by the material and has previously been used as a 
means of increasing the stability of NONOate-modified xerogel films.36 While all sols 
appeared to form homogenous gels, curing of xerogel films formed with the bulky ETMOS 
and BTMOS alkylalkoxysilanes required prohibitively long periods, most likely due to the 
decreased rates of hydrolysis of sterically hindered alkoxysilanes.31  Even after overnight 
aging of the sol, films cast from these materials and stored in a 70 °C oven for >2 weeks 
remained viscous and tacky.  Conversely, MPTMS/MTMOS sols aged 1-5 h rapidly 
solidified overnight under ambient conditions and formed clear, rigid films after 2 d drying at 
70 °C.  As such, MTMOS was selected as the backbone alkoxysilane in all further 
experiments. 
To establish conditions for optimal RSNO formation in the xerogel, films were 
prepared containing 20, 40, 60, and 80% (v:v total silane) MPTMS.  Nitrosation of the 
primary thiol of MPTMS was carried out by immersing the cured xerogel films in a solution 
of acidified nitrite containing 100 µM DTPA to reduce catalytic RSNO decomposition by 
adventitious Cu+ ions.  Reaction of the pendant thiols of the xerogel network with nitrous 
acid resulted in S-nitrosothiol formation (Eq. 3.1), and was accompanied by a concomitant 
color shift of the transparent xerogel film to a deep pink hue. 
RSH + HNO2 ⇄ RSNO + H2O    (3.1) 
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Figure 3.1. Chemical structures of (A) mercaptopropyltrimethoxysilane (MPTMS); 
(B) methyltrimethoxysilane (MTMOS); (C) ethyltrimethoxysilane 
(ETMOS); and (D) isobutyltrimethoxysilane (BTMOS). 
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The characteristic UV and visible absorbance maxima of the S-NO bond (at 336 and 545 nm, 
respectively) were monitored as a measure of the extent of thiol nitrosation.  After 3 h 
immersion in acidified nitrite, no further absorbance increases in the films were observed, 
indicating maximal RSNO formation (data not shown).  Extended soaking periods up to 24 h 
resulted in an overall decrease in measured absorbance.  Such decrease was attributed to 
thermal decomposition of formed RSNOs.  As shown in Figure 3.2, increasing the 
concentration of MPTMS in the xerogel films resulted in increased absorbance after 
nitrosation. A darker pink coloration of the more heavily thiol-functionalized films was 
readily apparent.  The color shift associated with nitrosation may thus provide a useful 
indication of the concentration of RSNOs (and thus NO-release potential) in a xerogel film. 
 Nitric oxide production from the RSNO-modified xerogels was measured via 
chemiluminescence as a real-time flux from individual films immersed in 37 °C pH 7.4 
PBS/DTPA containing physiological concentrations of glutathione.  Glutathione is the most 
common free thiol present in blood (~500 µM in healthy adults),37 and is believed to be one 
of the main small-molecule thiol sources for endogenous RSNO formation.38  Previous 
studies have indicated RSNO reaction with GSH as a potential pathway for NO production 
through an intermediate HNO species.21  Average NO fluxes from xerogel films prepared 
with 20-80% (v:v total silane) MPTMS are shown in Figure 3.3.  As expected, NO 
generation was found to scale with the percentage of MPTMS incorporated in the film, 
mirroring the increased absorbances shown in Figure 3.2.  In all cases, maximum NO flux 
was achieved within several minutes of xerogel immersion. Subsequent NO production 
decreased exponentially.  In 37 °C PBS, significant NO fluxes were maintained from the 
RSNO-modifed films for extended periods.  Films incorporating 40 and 80% MPTMS were 
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Figure 3.2. Absorbance spectrum of MTMOS films containing (―) 20% MPTMS; 
(−−) 40% MPTMS; (···) 60% MPTMS; and (−·−) 80% MPTMS (v:v 
total silane). 
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Figure 3.3. Average NO flux from RSNO-modified MPTMS/MTMOS films in 37 
°C PBS/DTPA.  Data points correspond to the average of 3 films 
incorporating (■) 80%; (●) 60%; (▲) 40% and (▼) 20% MPTMS (v:v 
total silane). [Inset:  Magnified view of 2 – 14 d NO release.] 
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capable of maintaining fluxes >0.5 pmol cm-2 s-1 for ~7 d and 14 d, respectively.  Such a 
duration of NO-release is a significant improvement over previously reported NONOate-
modified xerogels, wherein films of comparable thickness reached equivalent NO fluxes after 
only 24-72 h.7, 39   
The presence of free thiol in solution was found to have negligible effect on NO-
generation from RSNO-modified xerogel films as indicated by no observable change in NO 
production between films run in pure PBS or 500 µM GSH (data not shown).  As free thiol 
concentration was previously reported to have direct effects on NO production from 
RSNOs,21 the data indicate that the xerogel network may be sufficiently cross-linked to 
prohibit penetration of GSH into the xerogel interior.  Nitric oxide release was measured 
from films in the presence of DTPA copper chelator and protected from light, indicating the 
observed NO production proceeds via thermal-initiated homolytic cleavage of the RS-NO 
bond.  Indeed, NO production from RSNO-modified xerogel films was found to be highly 
temperature dependent (Figure 3.4).  Thermal decomposition is not surprising as primary S-
nitrosothiols are known to be quite thermally labile in the absence of intramolecular 
hydrogen bonding.40  The rapid initial burst of NO production observed may also be 
indicative of an autocatalytic reaction between freshly-formed RS· and neighboring RSNO 
groups:40 
RS· + RSNO → RS-SR + NO     (3.2)  
Due to the covalent immobilization of RSNO in the xerogel network, however, this effect 
would be expected to occur only over short time scales before the population of directly 
adjacent RSNOs is depleted.  
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Figure 3.4. Nitric oxide flux from RSNO-modifed 40% (v:v total silane) 
MPTMS/MTMOS films in pH 7.4 PBS / 100 µM DTPA solutions held 
at (A) 37 °C; (B) 25 °C; or (C) 0 °C.   
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  The long-term stability of RSNO-modified xerogels in 37 °C PBS solution was 
monitored by tracking siloxane network degradation through DCP-OES detection of leached 
Si.  After two weeks immersion, solutions in which 20-80% MPTMS/MTMOS films had 
been soaked showed negligible levels of xerogel fragmentation (<0.5 ppm).  In fact, detected 
Si in xerogel soak solutions was reduced compared to control samples containing only bare 
glass substrates, ostensibly due to masking of ~50% of the glass surface by the xerogel films.  
This level of stability is a marked improvement over previously described NONOate-
modified xerogel films in which significant fragmentation (8.2 mol %) was observed after  
14 d.36 
 
3.3.2. Antibacterial Properties of RSNO-Xerogels 
Implant-associated infection remains a serious problem in the U.S., with indwelling 
devices responsible for nearly half of the cases of nosocomial infection reported annually.5  
As these infections are a direct result of bacterial adhesion to implant materials, many active 
and passive strategies have been employed to decrease the amount of adherent bacteria on 
medical devices.8, 41  Nitric oxide is one such strategy, and materials modified with NONOate 
donors have previously shown promising reductions in surface bacterial adhesion compared 
to non-NO-releasing controls.42-44  To evaluate the antibacterial properties of RSNO-modifed 
xerogel films, the adhesion of P. aeruginosa, a common opportunistic pathogen, was 
evaluated on 60% MPTMS films exposed to highly concentrated (~108 cfu) bacterial 
suspensions both during initial periods of peak NO production and after 24 h immersion in 
37 °C PBS/GSH (to reduce overall NO fluxes from the films).  Statistically significant 
reductions (P < 0.05) of average bacterial surface coverage on RSNO-modified films versus 
non-nitrosated controls were observed in both cases (Figure 3.5).  Non-nitrosated control 
 81
Figure 3.5. Average P. aeruginosa adhesion to 60% (v:v total silane) 
MPTMS/MTMOS films during 1 h immersion in ~108 cfu/mL bacterial 
suspensions.  Average values were calculated from the mean of 5 
images on control or RSNO-modifed films (N = 3) soaked 0 or 24 h in 
37 °C PBS/GSH. 
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films presoaked for 0 and 24 h were both characterized by average surface coverages of ~ 
27%, indicating no significant change in the surface properties of the thiol-terminated films 
during extended exposure to PBS and GSH.  During this period, an approximate 16 fold 
reduction in average NO-flux from the nitrosated films (from ~165 to ~10 pmol cm-2s-1) 
resulted in an increase of observed bacterial surface coverage on the RSNO-modifed films 
from 4 ± 2 to 16 ± 7%, respectively.  This behavior is consistent with previous data showing 
reductions of bacterial adhesion to NO-releasing surfaces to be highly flux dependent.42  
Although the exact mechanism of the antibacterial effects of NO-releasing films is unknown, 
NO’s effect likely involves membrane damage due to lipid peroxidation45 or protein 
inactivation through nitrosation of key tyrosine and cysteine residues by the reactive 
oxidation products of NO.46  Direct transnitrosation reactions between RSNOs at the xerogel 
surface and bacterial thiols are possible,47 and may account for some of the observed 
reduction in bacterial coverage at RSNO-xerogels.  However, the majority of readily-
accessible surface RSNOs are likely depleted after 24 immersion in PBS/GSH via thermal 
homolytic cleavage and transnitrosation reactions with solution GSH.  We thus expect the 
observed antibacterial effects at longer periods are mediated by free NO radical.  Of note, the 
antibacterial properties of RSNO-modified films are maintained when exposed to 
concentrated bacterial suspensions for extended periods.  Previous studies using NONOate 
modified xerogels reported a general downward trend in bacterial adhesion to both control 
and NO-releasing surfaces when exposed to bacterial solutions for up to 4 h.  This decrease 
in adhesion was attributed to both changes in the surface properties of the hydrated films and 
alterations in bacterial metabolism and protein expression during long-term suspension in 
nutrient poor PBS.44  We observed a similar trend with RSNO-modifed films.  However, 
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whereas some NONOate-modified films showed insignificant antibacterial effects after as 
little as 1 h bacterial exposure,44 the bacterial surface coverage of RSNO-modifed xerogels 
remained approximately half that of non-nitrosated controls (1.3 ± 1.0 vs. 3.5 ± 1.2%, 
respectively) during a full 24 h exposure to concentrated bacterial suspensions.  This window 
of decreased bacterial adhesion is well in excess of the decisive “best treatment” period 6 h 
after device implantation during which introduced pathogens remain metabolically inactive.48 
Thus, RSNO-modifed xerogel coatings may provide a useful means of reducing bacterial 
adhesion to implanted biomedical devices during the period most critical to reducing 
implant-associated infection.  
 
3.3.3. Antithrombotic Properties of RSNO Xerogels 
Another significant impediment to the practical application of indwelling vascular 
medical devices is the tendency for platelets to activate and adhere to the material surface.49  
Such buildup is problematic for vascular grafts and stents as it restricts blood flow and may 
ultimately result in vessel occlusion.50  Likewise, platelet aggregation on intravascular 
sensors forms an effective barrier between sensor and analyte, leading to significantly 
impaired sensitivity to the surrounding environment.2  Nitric oxide’s inhibitory role in the 
platelet activation cascade provides a promising solution to such issues.  Multiple polymer 
coatings have displayed decreased thrombogenicity after modification to release NO via 
NONOate donor inclusion10, 51-53 or catalytically generate NO from blood components.54  
While small-molecule RSNO compounds have been widely studied as inhibitors of free 
platelet aggregation,55-57 limited studies have examined platelet aggregation to RSNO-
modified surfaces.  Bohl et al. demonstrated reductions in platelet adhesion to collagen-
coated glass surfaces after incubation of whole blood samples with RSNO-doped hydrogel 
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materials, but platelet adhesion to the hydrogel material itself was not described.23  Lewis and 
co-workers reported reductions in platelet adhesion to polyurethane and poly(ethylene 
terephthalate) polymers containing immobilized cysteines.58, 59  However, such materials 
were used to generate NO from a reservoir of solution RSNOs, and were not modified with 
RSNOs prior to the experiment.   
The effect of RSNO inclusion on platelet adhesion to xerogel materials was examined 
by exposing 40% MPTMS/MTMOS (v:v total silane) xerogel films to platelet-rich porcine 
plasma for 1 h.  Representative phase contrast images of platelet adhesion to RSNO-modifed 
surfaces and non-nitrosated controls are shown in Figure 3.6.  In general, overall platelet 
adhesion to MPTMS/MTMOS xerogels was quite low even at the elevated 2mM Ca2+ 
concentrations used to increase platelet activation in the experiment.  Nevertheless, 
modification with RSNO resulted in an approximate 50% decrease in average platelet 
coverage on nitrosated films versus controls (2.48 ± 1.16 vs. 4.61 ± 1.72%, respectively; P < 
0.05), as determined from the mean platelet surface coverage of 6 images per film (N = 8).  
The 50% reduction of platelet adhesion to RSNO-modified films versus controls is slightly 
lower than that seen previously for NONOate-modified xerogel films despite overall 
increased NO flux during the period of PRP exposure.60, 61  This smaller reduction may be 
attributed to the decreased overall adhesion observed at thiol-terminated controls versus 
amine-terminated NONOate xerogels and is in agreement with previous observations that 
reductions in platelet adhesion are not achieved at NO-releasing surfaces beyond a certain 
NO flux threshold.61  As discussed previously, during initial exposure to RSNO-modified 
films direct transnitrosation between surface xerogel RSNOs and thiol residues on plasma 
and platelet proteins may occur.  At longer time scales, however, the majority of RSNO-
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Figure 3.6. Representative phase-contrast images of platelet adhesion to (A) 
control and (B) RSNO-modified 40% (v:v total silane) 
MPTMS/MTMOS films after 1 h exposure to porcine PRP. 
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modifed xerogel films antithrombotic activity would be expected to result from NO 
generated from the inaccessible interior of the xerogel.  Previous work has found that NO 
fluxes as low as 0.4 pmol/cm2s are adequate for maintaining thromboresistive effects at a 
material surface.61  Nitric oxide release experiments indicate that RSNO-modified xerogels 
maintain fluxes over this threshold for up to 2 weeks.  During in vivo application, minimum 
NO flux requirements are likely to increase due to rapid NO scavenging by other free 
radicals, thiols, and heme proteins in blood.62  Nevertheless, the low thrombogenicity and 
extended NO-release durations observed indicate the use of RSNO-modified xerogel coatings 
represents an effective strategy for reducing platelet adhesion to implanted biomaterial 
surfaces.  
 
3.4. Conclusions 
 Nitric oxide-releasing polymer coatings have been shown to reduce biofouling and 
improve the performance of indwelling biomedical devices.  We have developed RSNO-
modified xerogel films as a novel and versatile class of NO-releasing materials.  Formed via 
condensation and subsequent nitrosation of mercaptoalkoxysilane precursors, RSNO-
modified xerogels showed tunable NO-release profiles with significantly improved durations 
of NO generation and solution stability compared to previously described NO-releasing 
xerogel films.  The antibacterial and antithrombotic benefits expected of NO-releasing 
materials were confirmed.  The power of sol-gel chemistry lies in its versatility.  Future work 
will focus on further exploring the range of NO-release characteristics attainable through 
modification of the mercaptoalkoxylsilane and alkylalkoxysilane precursors employed.  
Studies evaluating the potential benefits of RSNO-modifed materials as a means of 
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enhancing tissue compatibility and controlling the foreign body response during in vivo 
application are currently underway.  
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Chapter 4: 
Xerogel Optical Sensor Films for Quantitative Detection of Nitroxyl 
 
4.1. Introduction 
Nitrogen oxide compounds have become a topic of considerable interest in medicinal and 
biological chemistry.1  Nitric oxide (NO) is the most widely studied and well-known of these 
molecules, and multiple reports have catalogued the role of NO in numerous physiological 
processes, including vasodilation, neurotransmission, wound-healing, and thrombosis.2  As 
the effects of NO on physiology become better understood, more attention has focused on 
structurally similar nitrogen oxide compounds that may also have direct biochemical effects 
and/or function as intermediates in the NO-signaling cascade.  Nitroxyl (HNO), the one 
electron reduced congener of NO, is one such molecule that has displayed a number of 
interesting physiological effects.3  Nitroxyl’s high reactivity with thiols and metalloproteins 
has led to potential pharmaceutical application in protective preconditioning of ischemic 
injury,4 treatment for alcohol abuse through targeted inhibition of aldehyde dehydrogenase,5, 
6 and as an efficient means of enhancing left ventricular contractility in victims of congestive 
heart failure.7  These discoveries have led to efforts focusing on the design and development 
of new HNO-donor molecules and prodrugs.8-11  Research in this area has been hindered by 
an inability to easily monitor HNO.  Indeed, no simple method currently exists for the 
quantitative determination of HNO in solution.  In this chapter, this issue is addressed 
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through the development of optical sensors designed for the rapid quantitative screening of 
HNO released by nitroxyl-donor molecules.        
Despite their similarities, HNO and NO have distinct chemical properties and 
reactivity.  The relatively high standard reduction potentials for the formation of HNO from 
NO (< -0.4 V vs. NHE)12 preclude the creation of HNO from NO under most physiological 
conditions.  Conversely, while the oxidation of nitroxyl to NO would be expected to occur 
readily in vivo, this has not been observed.  Oxidation to NO occurs most readily from 
nitroxyl’s triplet-state anion form (NO-) which is not present in significant concentration at 
physiological pH due to a pKa > 11.13  The ground spin states of HNO and NO- are singlet 
and triplet, respectively, making proton transfer between the two species spin-forbidden and 
kinetically slow.13 The recently described biological activities of HNO-donor compounds 
thus reflect reactivity of the HNO molecule itself and not a transformation to NO.   
Knowledge of HNO chemistry lags behind that of other nitrogen oxides such as NO, 
which can in large part be explained by HNO’s greater reactivity and difficulties in its 
handling and quantitation.  Nitroxyl in solution undergoes dimerization to hyponitrous acid 
followed by rapid dehydration and the formation of nitrous oxide (N2O):  
HNO + HNO → [HONNOH] → N2O + H2O     (4.1) 
The study and application of HNO must therefore be accomplished by in situ generation of 
nitroxyl by HNO-donor molecules such as Angeli’s salt (Na2N2O3) which decomposes upon 
protonation to form HNO and nitrite: 
N2O32- + H+ → HNO + NO2-      (4.2) 
The situation is further complicated by the lack of a simple means to detect and 
quantify HNO.  While specialized techniques such as infrared chemiluminescence may 
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directly assay HNO,14 such procedures are impractical in most laboratories.  More 
commonly, indirect screening methods for HNO are employed.  Gas chromatographic 
detection of the N2O dimerization product is often viewed as a marker of HNO formation, 
but may be misleading as alternate NO reaction pathways not involving nitroxyl also result in 
the production of N2O.15, 16  A more selective strategy reported by Donzelli et al. employed 
the rapid reaction of HNO with thiols as a marker of HNO generation in biological systems.17  
Treatment of HNO producing systems with glutathione resulted in the formation of a 
sulfinamide reaction product that was subsequently detected via HPLC.  Another commonly 
employed strategy involves reaction of HNO with ferric heme-containing proteins such as 
metmyoglobin.18  In the presence of HNO, ferric hemes undergo reductive nitrosylation, 
resulting in detectable shifts in the absorbance spectrum of the enzyme.  This reaction 
provides a highly selective means of screening for HNO generation, but the resulting 
FeII(NO) complex is unstable in aerobic conditions and readily undergoes reoxidation and 
dissociation.  Ferric porphyrin analogues have been reported that undergo similar absorbance 
shifts upon reaction with HNO.19  While easier to handle than the bulky metmyoglobin 
protein, ferric porphyrins suffered from the same oxygen instability and also react with NO, a 
common interferent in HNO-generating systems.  Recently, Marti et al. reported on the 
kinetics of reductive nitrosylation of manganese porphyrins via HNO.20  The reaction of 
manganese(III) meso-tetrakis(4-sulfonatophenyl) porphyrinate (MnIIITPPS; Figure 4.1A) 
with nitroxyl: 
MnIIITPPS + HNO → MnII(NO)TPPS    (4.3) 
resulted in strong shifts in the absorbance spectrum and displayed no cross-reactivity with 
NO or catalytic decomposition of the Angeli’s salt HNO donor compound. This molecule
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A 
B 
Figure 4.1. Chemical structures of (A) MnIIITPPS and (B) generation-zero 
trimethoxysilyl-terminated PAMAMOS dendrimers. 
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may thus provide a simple and robust alternative to metmyoglobin for the selective detection 
of HNO.  Unfortunately, the resultant MnII(NO)TPPS complex was found to be unstable in 
the presence of O2 and rapidly dissociate back to MnIIITPPS.  The instability of the MnII(NO) 
complex in aerated solution makes it difficult to quantitatively determine HNO 
concentrations.  Complex formation/dissociation is slower than the HNO dimerization rate (8 
x 106 M-1 s-1),13 and thus a measured absorbance is not reflective of an instantaneous HNO 
concentration.  As such, HNO complexation at metal centers has been limited to 
nonquantitative screening procedures and qualitative tests for the presence of HNO. 
Herein, optical sensor coatings suitable for quantitative determination of HNO in 
solution were developed by increasing the stability of the MnII(NO)TPPS complex via 
encapsulation in an aminoalkoxysilane-based xerogel matrix.  Xerogels are polymeric 
materials formed through the catalytic hydrolysis and condensation of alkoxy-terminated 
silane precursors.21  While NO diffusion through aminoalkoxysilane-derived xerogels has 
been shown to occur readily, oxygen permeability in these materials is quite low.22  
Encapsulation of MnIIITPPS inside aminoalkoxysilane-xerogel films is thus expected to 
permit HNO diffusion while creating a localized anaerobic environment for the porphyrin, 
slowing dissociation of the MnII(NO)TPPS complex.  Over short periods, HNO complexation 
by MnIIITPPS in these films may be considered largely irreversible, resulting in the creation 
of a cumulative HNO trap.  By utilizing the detected rate of intra-film MnII(NO)TPPS 
formation, a kinetic strategy may be employed to estimate HNO concentrations.  
Aminoalkoxysilane-xerogel film properties were further optimized for this application 
through the inclusion of trimethoxysilyl-terminated poly(amidoamine-organosilicon) 
(PAMAMOS) dendrimers (Figure 4.1B).  Such dendrimers create hydrophilic nanodomains 
 99
in the material and speed HNO diffusion through the membrane, increasing sensitivity and 
allowing application of the sensor films in a convenient 96-well plate format.  The resulting 
HNO-sensing microtitre plates were used to quantify HNO and confirm the pH-dependent 
nature of nitroxyl generation from a recently described HNO/NO donor compound, sodium-
1-(isopropylamino)diazene-1-ium-1,2-diolate (IPA/NO).23-25   
 
4.2. Materials and Methods 
Manganese(III) meso-tetrakis(4-sulfonatophenyl) porphine chloride (MnIIITPPS) was 
purchased from Frontier Scientific (Logan, UT).  
(Aminoethylaminomethyl)phenethyltrimethoxysilane (AEMP3) was purchased from Gelest 
(Tullytown, PA). Methyltrimethoxysilane (MTMOS) and diethylenetriamine-pentaacetic acid 
(DTPA) were purchased from Fluka.  Generation zero (G-0) trimethoxysilyl-terminated 
PAMAMOS dendrimer (10 wt% in isopropanol) was purchased from Aldrich (Milwaukee, 
WI).  Angeli’s Salt (disodium diazen-1-ium-1,2,2-triolate; Na2N2O3) was purchased from 
Cayman Chemical (Ann Arbor, MI).  Sodium-1-(isopropylamino)diazene-1-ium-1,2-diolate 
(IPA/NO) was provided as a generous gift from Dr. Katrina Miranda at the University of 
Arizona. Nitric oxide (99.5%) was purchased from National Welders Supply (Durham, NC). 
Untreated polystyrene round-bottom 96-well microtitre plates were purchased from Fisher 
Scientific.  Other solvents and chemicals were analytical-reagent grade and used as received. 
Distilled water was purified to 18.2 MΩ·cm with a Millipore Milli-Q Gradient A-10 water 
purification system (Bedford, MA). 
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4.2.1. Response of MnIIITPPS to NO and HNO    
The selectivity of HNO binding over NO by MnIIITPPS in aerobic conditions was 
examined in a PerkinElmer Lamba 40 UV/Vis spectrophotometer (Norwalk, CT).  A ~0.01 
M stock solution of the Angeli’s salt HNO donor was prepared in 0.01 M NaOH and stored 
on ice until use.  A deoxygenated, saturated NO stock solution (~1.9 mM) was created by 
sparging 30 mL pH 7.4 10 mM phosphate-buffered saline (PBS) with Ar for 40 min, and then 
bubbling with NO for 2 h.  Aliquots (20-100µL) of each solution were mixed with 2 mL 5.5 
µM MnIIITPPS in 10 mM PBS at room temperature, and the visible absorbance spectrum of 
the resulting solution was monitored for ~2 h. 
 
4.2.2. Xerogel Film Preparation   
Nitroxyl-sensing films were first evaluated as thin films on glass slides using a 
previously described 20/80% (v:v total silane) AEMP3/MTMOS aminoalkoxysilane-xerogel 
formulation.22, 26  Briefly, MTMOS (160 µL) and ethanol (200 µL) were combined with 0.25 
- 2 mM (aq) MnIIITPPS solution (11 µL).  After 5 min sonication, AEMP3 (40 µl) was added 
and sonicated for an additional 5 min.  The resulting sol was cast in 10 - 30 µL aliquots onto 
9 x 25 mm2 glass substrates that had been previously sonicated 20 min in ethanol, dried under 
N2, and UV/O3 cleaned for 20 min in a BioForce TipCleaner (Ames, IA).  The resulting films 
were allowed to dry a minimum of 3 d in ambient conditions prior to subsequent 
characterization. 
 
4.2.3. Film Characterization 
Film depths and the corresponding volume of cured xerogel on glass slides were 
determined using a Tencor Alpha-Step 200 Profilometer (San Jose, CA). Spectral 
 101
characterization of MnIIITPPS encapsulated in AEMP3/MTMOS films was performed by 
affixing the slides inside PBS-containing (2 mL) cuvettes normal to the light path of the 
spectrophotometer.  The extinction coefficient of immobilized MnIIITPPS was determined by 
plotting the measured 467 nm absorbance of xerogel films (depth ~29 µm) containing 0.32 – 
2.55 x 10-7 moles/cm3 MnIIITPPS versus porphyrin concentration.  Aliquots of 10-100 µL 
Angeli’s salt stock solution (~0.01 M in 10 mM NaOH) were added to pH 7.4 PBS to a final 
volume of 2.5 mL.  Nitroxyl-sensing xerogel films that had been previously hydrated in PBS 
for a minimum of 20 min were placed in cuvettes with 2 mL of the Angeli’s salt/PBS 
solution.  The rates of MnII(NO)TPPS formation and dissociation in AEMP3/MTMOS films 
were determined by monitoring changes in the absorbance maxima of MnIIITPPS and 
MnII(NO)TPPS at 467 and 432 nm, respectively, for ~2 h.  The concentrations of Angeli’s 
salt stock solutions were determined via Beer’s law prior to each experiment by monitoring 
the absorbance at 250 nm  (ε = 8000 M-1 cm-1).27 
 
4.2.4. Kinetic HNO Quantification 
Stabilization of the MnII(NO)TPPS complex in AEMP3/MTMOS sensor films 
provides a means for kinetic quantification of HNO in solution.  By eliminating the uncertain 
rate of competitive complex dissociation, steady-state reaction kinetics for HNO-donor 
systems are greatly simplified.  Calibration with a well-characterized HNO-donor such as 
Angeli’s salt under controlled reaction conditions allows determinations of an experimental 
kinetic coefficient (kon) for MnII(NO)TPPS formation in xerogel films.  The resulting rate 
constant may then be used to extrapolate solution HNO concentrations generated by alternate 
HNO-donors.  In our system, three kinetic expressions (Eq. 4.4 – 4.6) were considered during 
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calibration, corresponding to Angeli’s salt decomposition (Eq. 4.2), MnII(NO)TPPS 
formation (Eq. 4.3), and HNO scavenging through dimerization (Eq. 4.1): 
][/][ 1 ASktHNO −=∂∂       (4.4) 
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where k1[AS] is the rate of Angeli’s salt decomposition, and k2 is the kinetic coefficient of 
the HNO dimerization reaction (8 x 106 M-1 s-1).13  Angeli’s salt decomposition rates were 
determined in PBS by monitoring the decrease in 250 nm absorbance over 60 min and fitting 
to an exponential decay model (absorbance = Ae-kt + c).28 For the experimental conditions 
employed herein (25 °C, pH 7.4, 10-4 DTPA, aerobic), k1 was calculated at 8.1 x 10-4 s-1.  
After determination of kon via Angeli’s salt calibration, the observed rates of MnII(NO)TPPS 
formation were used to calculate HNO concentrations according to: 
][
/])([][
TPPSMnk
tTPPSNOMnHNO III
on
II ∂∂=      (4.8) 
where [MnII(NO)TPPS] and [MnIIITPPS] concentrations in the film were monitored 
spectroscopically at 432 and 467 nm, respectively.  Considering xerogel film thicknesses 
(~29 µm) as the optical path length, the extinction coefficient of MnIIITPPS encapsulated in 
AEMP/MTMOS was calculated to be 90000 M-1 cm-1 at 467 nm via Beer’s law.  Although 
complete conversion of MnIIITPPS to MnII(NO)TPPS was not attainable even with large 
 103
excesses of Angeli’s salt, the differential rates of absorbance decrease at 467 nm and increase 
at 432 nm were used to estimate ε ~ 160000 M-1 cm-1 at 432 nm for MnII(NO)TPPS.   
 
4.2.5. Xerogel-Coating of 96-well Microtitre Plates 
Nitroxyl-sensing xerogel films were optimized for deposition in 96-well plates.  Sols 
were created using the general reaction scheme described above and varying the following:  
the volume and identity of solvent employed, including methanol, ethanol, isopropanol, and 
n-butanol; the concentration of aqueous MnIIITPPS solution included in the sol (2-8 mM); 
and the volume percentage of AEMP3 to MTMOS employed (10-50%).   Aliquots (4-10 µL) 
of the resulting sols were pipetted into the bottom of round-bottom 96-well polystyrene 
microtitre plates and allowed to cure under ambient conditions.  Xerogel films were 
evaluated for their transparency, smoothness, stability, and detectable absorbance at 467 nm. 
Film thickness was monitored via optical microscopy using a Zeiss Axiovert 200 inverted 
microscope.   
 
4.2.6. Microtitre Plate Sensor Optimization 
Sols containing 40/60% (v:v) AEMP/MTMOS and ~0-2% PAMAMOS dendrimer 
(v:v total silane) were created by shaking MTMOS (120 µL), 10% (w:w) PAMAMOS 
dendrimer in isopropanol (0 – 40 µL), methanol (420-380 µL; total methanol and 
PAMAMOS volume = 420 µL), and 4mM (aq) MnIIITPPS (11 µl) for 10 min, followed by 
the addition of AEMP3 (80 µL) and a subsequent 5 min additional shaking.  Aliquots (4-10 
µL) of the resulting sol were pipetted into wells and allowed to cure for a minimum of 3 d 
under ambient conditions.  Initial screening procedures monitoring the rate of MnII(NO)TPPS 
complex formation in the gel were performed using a Labsystems Multiskan RC plate reader 
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outfitted with 430 and 467 nm narrow bandpass interference filters (10 nm full-width at half 
max) purchased from Edmund Optics (Barrington, NJ).  All wells were soaked with 50-100 
µL PBS for a minimum of 3 h prior to use to achieve a steady 430 nm baseline absorbance.  
To initiate HNO generation, 40 µL of the initial Angeli’s salt stock solution was mixed and 
shaken with 1960 µL pH 7.4 PBS containing 100 µM DTPA for 30 s.  The pre-soaked wells 
were emptied and 10-100 µL of the Angeli’s salt-PBS solution and a balance PBS/DTPA 
was added to wells for a total volume of 100 µL.  To ensure accurate kinetics, care was taken 
so that timing remained consistent.  The HNO-sensing wells were loaded and the recording 
of kinetic absorbance data began at exactly 40 and 60 s, respectively, after initial mixing of 
Angeli’s salt and PBS.  The absorbance at 430 nm, corresponding to formation of 
MnII(NO)TPPS in the films, was monitored every 10 s for 15 min.  Initial rates were obtained 
from the slope of linear fits of the first 5 min of collected data.  Only fits with R2 ≥ 0.99 were 
retained for subsequent calculations. After optimization, characterization of the most 
favorable sensor formulation’s dynamic range and sensitivity was performed following the 
same procedures with a monochrometer-equipped Molecular Devices Spectramax 340PC 
plate reader (Sunnyvale, CA) capable of monitoring both 432 and 467 nm absorbance 
maxima simultaneously. Baseline absorbance from control xerogel films containing no 
MnIIITPPS was subtracted from all measurements.  
 
4.2.7. Oxygen Permeability Testing 
The permeability of oxygen (O2) through PAMAMOS-modified HNO-sensing 
xerogels was examined by measuring O2 reduction at xerogel-coated electrodes.  Sols 
containing 40/60% (v:v total silane) AEMP3/MTMOS with ~ 0, 0.25, 0.5, 1.0, and 2.0 % 
(v:v total silane) trimethoxysilyl-terminated PAMAMOS dendrimer were prepared using the 
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formula described above.  Control MTMOS sols containing no AEMP3 were synthesized by 
shaking MTMOS (750 µL) with 0.1 M HCl (140 µL) for 10 min.  Platinum electrodes (2 mm 
dia.) were mechanically polished with a 0.05 µM alumina slurry, rinsed, sonicated in water 
for 15 min, coated with 2 µL of the corresponding sol and allowed to dry for three days.  The 
diffusion of O2 through the xerogel films as a function of PAMAMOS amount was examined 
with a CH Instruments 660A potentiostat (Austin, TX).  A three-electrode system consisting 
of the xerogel-modified Pt electrode, Pt wire auxiliary electrode (0.5 mm), and a Ag/AgCl 
(3.0 M KCl) reference electrode was used to monitor O2 reduction.  Electrodes placed in 40 
mL of PBS (100 µM DTPA, pH 7.4) with constant stirring were exposed to atmospheric 
levels of O2. Current was recorded at an applied potential of -0.65 V vs. Ag/AgCl with a 
sampling frequency of 1 Hz.  Xerogel permeability to oxygen was determined by taking the 
ratio of the peak current for O2 for the xerogel-coated electrode to that of the corresponding 
uncoated electrode. Coated electrodes were soaked in PBS (100 µM DTPA, pH 7.4) for 3 h 
prior to the electrochemical experiments to mimic hydration conditions of the HNO sensing 
films at time of use. 
 
4.2.8. HNO-Generation from IPA/NO 
Generation of HNO from an IPA/NO nitroxyl donor compound was quantified using 
the developed 96-well microtitre plate sensing scheme.  Sols containing 40/60% (v:v total 
silane) AEMP3/MTMOS and ~0.25% PAMAMOS dendrimer (v:v total silane) were 
prepared and pre-hydrated as described above.   An IPA/NO stock solution was prepared by 
dissolving 29.3 mg IPA/NO in 1 mL 0.01 M NaOH.  The solution was stored at -20 °C until 
use.  Immediately prior to measurement, 80 µL of the IPA/NO stock was added to 1.92 mL 
10 mM PBS/100µM DTPA, and shaken for 30 s.  Using the strategy described above, 25-100 
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µL of the IPA/NO-PBS solution was added to wells containing a balance of PBS/DTPA 
buffer for a total volume of 100 µL.  The formation of MnII(NO)TPPS from MnIIITPPS was 
monitored by measuring the absorbance at 432 and 467 nm, respectively. The effect of pH on 
HNO production was examined by adjusting the starting pH of the PBS solution employed 
prior to mixing (pH 3-10).  To compensate for the poor buffering capacity of PBS outside the 
neutral pH region, final solution pH was determined after IPA/NO stock addition.  The 
concentrations of IPA/NO stock solutions were determined prior to each experiment by 
monitoring absorbance at 250 nm  (ε = 10000 M-1 cm-1).25  
  
4.3. Results and Discussion 
 
4.3.1. MnIIITPPS HNO Selectivity 
The selectivity of MnIIITPPS for complexation of HNO over NO in oxygenated media 
was examined directly using a UV/Vis spectrophotometer.  As expected, mixing MnIIITPPS 
with HNO generated via Angeli’s salt resulted in a rapid increase in the absorbance of the 
solution at 423 nm and a concurrent decrease in absorbance at 467 nm, corresponding to the 
formation of MnII(NO)TPPS from MnIIITPPS (Figure 4.2).  Maximum 423 nm absorbance 
occurred within 5 min of HNO addition and then slowly decreased to baseline absorbances 
within 90 min.  Negligible absorbance change was observed upon addition of saturated NO 
solution, indicating that MnIIITPPS retains its selectivity for HNO in aerobic solution 
conditions.   
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Figure 4.2. The UV/Vis spectral response of (―) MnIIITPPS in pH 7.4 PBS upon 
exposure to 100 µM (---) Angeli’s salt and (···) NO.  Spectra were 
recorded 8 min after the addition of Angeli’s salt or NO. 
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4.3.2. MnII(NO)TPPS Formation in Xerogel Films 
Amine-terminated xerogels have previously been used in the production of multiple 
optical (e.g., pH),29 amperometric (e.g., CO2, NO)30, 31 and enzyme-based (e.g. glucose)32, 33 
sensors and biosensors.  While the diffusion of NO through these materials was rapid, the 
intrinsic permeability of O2, a highly nonpolar molecule, was quite low.34  Robbins and co-
workers measured oxygen permeability at xerogel-coated electrodes, and reported that the 
oxygen permeability at a Pt electrode coated with 20/80% (v:v total silane) AEMP3/MTMOS 
was diminished by ~97% compared to a bare electrode.22  By encapsulating MnIIITPPS in 
this material we thus sought to provide an anaerobic localized environment for the porphyrin, 
slowing dissociation of the MnII(NO)TPPS complex formed upon reaction with HNO.  
Spectroscopic observation of MnIIITPPS encapsulated in an AEMP3/MTMOS xerogel 
revealed the presence of both the expected absorbance maxima at 467 nm and a second 
unidentified peak centered at 445 nm.  Upon immersion of the film in PBS, the 445 nm peak 
disappeared rapidly concomitant with a rise in 467 nm absorbance.  This behavior may be 
attributed to temporary association of the Mn center with surface silanols or amines present 
in the dry xerogel film.  All films were hydrated a minimum of 20 min prior to HNO 
exposure to overcome this effect.  Upon introducing HNO, a rise and fall of absorbance 
maxima at 432 and 467 nm, respectively, were observed. While red-shifted compared to the 
423 nm absorbance maximium observed in solution, the correlation between the 432 and 467 
nm maxima is a strong indication that 432 nm absorbance may be assigned to MnII(NO)TPPS 
formation via reductive nitrosylation of MnIIITPPS.  As shown in Figure 4.3, encapsulation 
of the porphyrin in AEMP3/MTMOS xerogel resulted in a dramatic decrease in 
MnII(NO)TPPS dissociation.  While MnII(NO)TPPS formation was slowed relative to in
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Figure 4.3. MnII(NO)TPPS formation in (■) AEMP3/MTMOS or (x) free in 
aerobic PBS as measured by absorbance at 432 or 423 nm, respectively, 
after the addition of 100 µM Angeli’s salt. 
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solution, the resulting complex remained stable over the time course of the experiment (2 h), 
indicating that MnIIITPPS in AEMP3/MTMOS functions largely as a cumulative HNO trap 
over short periods. 
 
4.3.3. Microtitre Plate Sensor Optimization via PAMAMOS 
Long-term exposure (>24 h) of HNO-sensing films to media containing ambient O2 
concentrations was found to regenerate MnIIITPPS and restore initial absorbance maxima. 
However, the largely irreversible short-term nature of HNO complexation in 
AEMP3/MTMOS films makes HNO quantitation with a single film impractical for analytical 
measurements.  To maximize the utility of HNO-sensing films, xerogel coatings were 
optimized for use in a 96-well microtitre plate format.  Such a configuration allows a large 
number of HNO assays to be run in parallel while permitting calibration to be performed at 
the time of analysis to account for variations in individual films and changes that may occur 
in the xerogel with time.  Curing of sols deposited in flat-bottom polystyrene microtitre 
plates resulted in clustering of xerogel around the edges of the well and the formation of 
concave films.  More uniform coatings were achieved using round-bottom plates.  In general, 
the reduced sensitivity of the microtitre plate reader format versus the UV/Vis 
spectrophotometer required thicker xerogel layers and larger MnIIITPPS concentrations to 
bring measured absorbance values above baseline noise.  Several solvents and reaction 
conditions were evaluated to form reproducibly thicker, crack-free xerogel films in the 
round-bottom wells.  Ultimately, a mixture of 40/60% (v:v total silane) AEMP3/MTMOS, 4 
mM MnIIITPPS (aq) and methanol (co-solvent) provided the proper balance between sol-gel 
condensation rates and solvent evaporation, resulting in smooth, uniform films of adequate 
thickness (~90-140 µm, for 6-10 µL sol cast). 
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Unfortunately, nitroxyl diffusion through pure AEMP3/MTMOS films proved 
inadequate for the sensitivity constraints imposed by the 96-well plate format.  To increase 
the formation rate of MnII(NO)TPPS, trimethoxysilyl-terminated PAMAMOS dendrimers 
were evaluated as a means of selectively enhancing HNO permeability through the xerogel. 
Dvornic and co-workers previously reported on the utility of such macromolecules to form 
honeycomb-like hydrophilic-nanodomained networks upon sol-gel hydrolysis and 
condensation.35, 36  The generation-zero PAMAMOS dendrimers employed are characterized 
by a branched hydrophilic polyamidoamine interior surrounded by 8 terminal trimethoxysilyl 
groups enabling their incorporation into the surrounding xerogel structure via condensation 
reactions.  By incorporating PAMAMOS dendrimers as bridging molecules in the 
surrounding AEMP3/MTMOS network, hydrophilic pockets were created in the final 
xerogel, providing preferential enhancement of HNO diffusion over the more lipophilic O2 
molecule.  The percentage change in 430 nm absorbance observed from xerogel films 
containing ~0.25-2.0% (v:v total silane) PAMAMOS dendrimer upon introduction of 
Angeli’s salt is shown in Figure 4.4.  In films containing ~0.25% (v:v total silane) 
PAMAMOS, the initial rates of MnII(NO)TPPS formation increased by nearly an order of 
magnitude versus rates measured in pure AEMP3/MTMOS films.  Surprisingly, increasing 
the percentages of PAMAMOS >0.25% resulted in an overall decrease in the rate of 
MnII(NO)TPPS formation measured in the films.  This effect may be attributed to increased 
competition with oxygen as larger amounts of the PAMAMOS bridge would lead to less 
dense crosslinking of the alkoxysilane precursors and thus a more open xerogel network.  
Indeed, macroscopic holes were observed in multiple wells at percentages of PAMAMOS 
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Figure 4.4. Initial rates of MnII(NO)TPPS formation detected as 430 nm 
absorbance in AEMP3/MTMOS films modified with 0-2% (v:v total 
silane) trimethoxysilyl-terminated PAMAMOS dendrimers upon the 
addition of 320 µM Angeli’s salt/PBS.    
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inclusion above 2% likely due to termination of growing silane networks by the inclusion of 
multiple dendrimers. 
 
4.3.4. Oxygen Permeability in PAMAMOS-Modified Films 
To evaluate the effect of PAMAMOS dendrimer incorporation on O2 diffusion in the 
HNO-sensing xerogel films, the amperometric response of xerogel-coated O2-reducing 
electrodes was examined. Films comprised of 40/60% (v:v total silane) AEMP3/MTMOS 
with ~0, 0.25, 0.5, 1.0 and 2.0% (v:v total silane) trimethoxysilyl-terminated PAMAMOS 
dendrimers were tested and compared to control films consisting of 100% MTMOS.  
Initially, the amperometric response of bare Pt electrodes to ambient concentrations of 
dissolved O2 was evaluated.  The electrodes were then coated with MTMOS, 
AEMP3/MTMOS, and PAMAMOS-modified xerogels.  The change in oxygen peak current 
was determined and correlated to percent O2 permeability relative to the bare electrode 
(Table 4.1).  Whereas MTMOS-only control films retained nearly 70% of the oxygen signal 
of a bare electrode, the oxygen permeability of pure AEMP3/MTMOS films was reduced to 
~8% of the value observed for bare electrodes.  Of note, ANOVA statistical tests showed no 
significant oxygen permeability difference (P > 0.05) in films modified with 0.25% 
PAMAMOS compared to AEMP3/MTMOS alone. While O2 permeability in all 
PAMAMOS-modified AEMP3/MTMOS films remained well below the permeability of 
MTMOS controls, all films with >0.25% PAMAMOS incorporation were found to yield 
small, but statistically significant increases in oxygen permeability compared to both 0 and 
0.25% PAMAMOS-modified xerogels.  Thus, enhanced oxygen permeation may account for 
the downward trend in the MnII(NO)TPPS formation rates observed with increasing 
%PAMAMOS inclusion.  Nevertheless, the inclusion of small percentages of PAMAMOS
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% PAMAMOS 
(v:v total silane) 
O2 Permeability 
(%) a 
ANOVA P value        
(vs. 0.0 % PAMAMOS) 
ANOVA P value       
(vs. MTMOS Control) 
0.0 8.19 ± 1.90 1 3.23E-03 
0.25 9.61 ± 0.23 2.56E-01 5.44E-04 
0.5 16.92 ± 1.08 1.64E-03 1.90E-04 
1.0 14.69 ± 0.72 4.57E-02 4.84E-03 
2.0 15.98 ± 0.58 5.68E-03 9.24E-04 
MTMOS 
Control 
68.90 ± 12.79 3.23E-03 1 
a relative to uncoated electrode 
Table 4.1. Oxygen permeability of 0-2% (v:v) PAMAMOS-modified 
AEMP3/MTMOS xerogels and controls.  
 115
dendrimer in the AEMP3/MTMOS network provided a clear enhancement in the sensitivity 
of HNO-sensing films with minimal detrimental effects on oxygen permeability.   
 
4.3.5. Nitroxyl Sensing 
Nitroxyl sensor films comprised of the optimized xerogel formulation were fabricated 
by depositing 8 µl of 40/60% (v:v total silane) AEMP3/MTMOS with 0.25% (v:v total 
silane) PAMAMOS dendrimer in each well of a 96-well microtitre plate and cured up to 7 d 
before use.  Sol-gel condensation reactions continue to occur after xerogel solidification, and 
thus long term storage may have detrimental effects on sensor sensitivity as the siloxane 
network of the gel becomes more densely crosslinked.37  As such, sensor calibration at the 
time of nitoxyl detection is important.  Calibration of the sensor plate was performed by 
monitoring the initial rates of MnII(NO)TPPS formation in the films upon exposure to 
Angeli’s salt and fitting the response to Eq. 4.7.  A representative response curve is shown in 
Figure 4.5.  Obtaining a strong coefficient of determination (R2 ≥ 0.99) at rates < 8 x 10-9 M-1 
s-1 (corresponding to ~13 µM Angeli’s salt) became difficult due to intrinsic noise.  Rates > 
~1 x 10-7 M-1 s-1 (~1 mM Angeli’s salt) began to deviate from the theoretical model of Eq. 
4.7.  Fitting the initial rates over this concentration range using Eq. 4.7 resulted in an 
experimental kon ~1 x 103 M-1 s-1 for MnII(NO)TPPS formation in the xerogel films.  As 
expected, this value was significantly lower than that established by Marti for MnIIITPPS in 
anaerobic solution (4 x 104 M-1 s-1)20 due to diffusion constraints imposed by encapsulation 
of the porphyrin in the film.  Substitution of these values into Eq. 4.8 resulted in an estimated 
dynamic range of 24-290 nM HNO, a relatively small range reflective of the rapid 
scavenging of HNO via dimerization at higher nitroxyl concentrations limiting free HNO in 
solution.  Example real-time HNO release data from ~700 µM and 50 µM Angeli’s salt 
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Figure 4.5. Initial rates of MnII(NO)TPPS formation in  40/60% (v:v total silane) 
AEMP3/MTMOS films modified with 0.25% (v:v total silane) 
trimethoxysilyl-terminated PAMAMOS dendrimers.  Data corresponds 
to the average of 7 individual films. [Inset: Magnified view of linear 
region.] 
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solutions derived via Eq. 4.8 by spectroscopically monitoring intra-film MnIIITPPS 
concentrations and MnII(NO)TPPS formation rates over 60 s time intervals are shown in 
Figure 4.6.  At the larger HNO-donor concentration, a steady decrease in solution HNO was 
observed due to the prevalence of the second order HNO dimerization reaction and N2O 
formation.  Dimerization was slowed considerably at the lower HNO concentration. Further 
improvement of the working dynamic range of HNO-sensing films would therefore best be 
achieved by increasing kon, expanding the range of measurable initial rates and improving 
sensitivity at lower donor concentrations.  The rates of MnII(NO)TPPS formation scale with 
the square root of the nitroxyl donor employed (Eq. 4.7). However, sensor response can be 
approximated as linear at low donor concentrations (Figure 4.5 inset).  In this region, a 
sensitivity of ~ 2.5 x 10-10 M-1 s-1 (change in initial rates) per µmol Angeli’s salt was 
obtained, correlating to an estimated minimum resolvable shift of approximately 10 nM 
HNO as derived from twice the average standard deviation of the measured initial rates.  
Although sensors regenerated by long-term (>24 h) exposure to PBS containing ambient O2 
concentrations showed consistent response to HNO, the lengthy soaking periods required 
often had detrimental effects on xerogel stability, leading to cracking and peeling of the 
xerogel films.  Because of this issue and the relative ease of film fabrication, films were 
typically utilized only once. 
To illustrate the usefulness of the developed HNO-sensing films for the screening of 
HNO-donor compounds, nitroxyl production from the N-bound diazeniumdiolate (NONOate) 
compound IPA/NO was measured using the microtitre plate format.  Formed upon exposure 
of amines to high pressures of NO, NONOate compounds have been widely employed as 
NO-storage and delivery agents.  Recent studies indicate that primary amine NONOates such  
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Figure 4.6. Time-resolved HNO concentrations obtained from (■) 700 µM and (x) 
50 µM Angeli’s salt in pH 7.4 PBS.  Rates were acquired over 60 s 
intervals. 
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as IPA/NO have the capacity to produce both NO and HNO under certain conditions.25, 38  
While overall decomposition of N-bound NONOates is proton initiated, HNO production is 
predicted to be thermodynamically favored over NO at high pH values.26 The transition of 
IPA/NO from a HNO to NO-donor is proposed to occur gradually, with NO production 
increasing at pH <7 at the expense of HNO generation.  This behavior was experimentally 
confirmed by examining the rates of MnII(NO)TPPS formation using the HNO-sensing 
plates.  After Angeli’s salt calibration, nitroxyl concentrations generated from 6.1 mM 
IPA/NO in pH 4-10.5 PBS were determined at 15 min time intervals (Figure 4.7).  The 
nitroxyl concentrations at elevated pH trended upwards with decreasing pH to near neutral 
conditions, after which HNO concentrations began to decline.  Gas evolution did not follow 
this trend, but rather was observed to consistently increase at decreasing pH values.  
Enhanced gas evolution is consistent with increased proton-initiated decomposition rates of 
the NONOate donor, and a strong indication that the reduced HNO concentrations detected 
were the result of an increase in IPA/NO decomposition to NO.  Optical noise due to bubble 
formation in the sensor light path likely contributed to the high variability in recovered HNO 
concentrations observed at low pH in Figure 4.7.  To compare the HNO production 
efficiencies of IPA/NO versus Angeli’s salt, HNO concentrations were calculated from 1-6 
mM IPA/NO in pH 7.4 PBS over 15 min intervals and compared to equivalent HNO 
concentrations derived from Angeli’s salt (Figure 4.8).  Despite similar rates of donor 
decomposition,27 generation of equivalent HNO concentrations required significantly larger 
concentrations of IPA/NO.  Such a trend is consistent with previous reports of decreased 
metmyoglobin reductive nitrosylation efficiency by equimolar amounts of IPA/NO and 
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Figure 4.7. Effect of pH on HNO production from 6.1 mM IPA/NO in PBS. Data 
corresponds to the average of 7 individual films. 
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Figure 4.8. Concentrations of HNO versus required donor concentrations of (■) 
IPA/NO or (x) Angeli’s salt in ph 7.4 PBS.  Data corresponds to the 
average of 7 individual films.  Note the scale break along the x-axis. 
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Angeli’s salt,25 and may be attributed to the concurrent formation of NO that is both formed 
competitively with HNO and scavenges existing HNO from solution.13   
 
4.4. Conclusions 
Despite a growing number of potential pharmaceutical applications, difficulties 
associated with nitroxyl detection and quantification have complicated the study of HNO and 
the characterization of new HNO-donor compounds. Through encapsulation of HNO-
selective MnIIITPPS within the anaerobic local environment of an aminoalkoxysilane xerogel 
membrane the first reported optical sensor films suitable for the quantitative determination of 
HNO were developed in a convenient 96-well microtitre plate format.  At present, the rapid 
dimerization of HNO at high concentrations and relatively slow rate of HNO complexation in 
the xerogel film limit optimal sensor performance to environments with restricted HNO 
scavenging conditions and a narrow dynamic range.  Future work should focus on increasing 
both the sensor range and sensitivity by increasing the rate of HNO diffusion into the films 
and the corresponding experimental kinetic coefficient (kon) for intra-film complex 
formation.  Nevertheless, the described HNO-sensing plates provide a simple, rapid means 
for determining HNO concentrations in aerobic solution and may thus prove useful as tools 
for characterizing novel HNO-releasing compounds.  
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Chapter 5: 
Summary and Future Directions 
 
5.1. Summary 
The versatility of sol-gel chemistry makes xerogels an extremely adaptable and useful 
medium for creating sensor membranes and devices.  Through manipulation of sol-gel 
processing conditions and selective incorporation of functional organoalkoxysilane 
precursors into the siloxane backbone of the material, the physical and chemical properties of 
the xerogel can be tuned for a desired application.  Sensor membranes can be optimized for 
enhanced analyte selectivity and increased material compatibility with an intended sensing 
environment.  Developing strategies to best utilize the unique properties of xerogel 
membranes for the enhancement of chemical sensor function has been the major focus of my 
doctoral work.   
Chapter 2 detailed the design and development of a xerogel-based nitric oxide (NO)-
releasing optical pH sensor.  Real-time pH detection was achieved by monitoring the ratio of 
fluorescent emission from the acid and base isomers of the pH-sensitive fluorophore 
seminaphthorhodamine-1 carboxylate (SNARF-1) physically doped into xerogel films on 
tapered fiber optic probes.  Direct immobilization of SNARF-1 in N-diazeniumdiolate 
(NONOate)-modifed NO-releasing xerogels resulted in significantly reduced sensitivity to 
bulk pH due to the low solution permeability of NONOate-modified xerogels and localized 
pH buffering by covalently-bound aminoalkoxysilanes.  However, a two-layer sensor 
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configuration wherein the NONOate-modified film was deposited directly onto the fiber-
optic surface and the SNARF-1 pH indicator was immobilized in an overlying tetramethyl 
orthosilicate (TMOS) xerogel dramatically improved sensor performance.  Two-layer sensor 
response to pH throughout the physiological range (pH 7.0-7.8) was fast (≤14 ± 2 s) and 
linear.  An estimated minimum resolvable pH shift of ~0.04 pH units was determined.  Real-
time chemiluminescence measurements confirmed the presence of the overlying indicator-
doped TMOS layer had no inhibitory effect on NONOate formation or NO release.  The NO-
releasing coatings were capable of maintaining NO fluxes >0.4 pmol cm-2 s-1 up to 16 h, and 
enhanced biocompatibility of the sensor films was confirmed by exposure to porcine platelet-
rich plasma.  
In Chapter 3, a novel class of NO-releasing xerogel coatings to improve sensor 
biocompatibility was described.  S-nitrosothiol (RSNO)-modifed xerogels were formed 
through the co-condensation of mercaptopropyltrimethoxysilane (MPTMS) and 
methyltrimethoxysilane (MTMOS) precursors.  Nitrosation of the covalently-bound pendant 
thiols of MPTMS resulted in deep pink xerogel films capable of releasing NO for 
significantly longer periods than previously described NONOate-modifed xerogels.  
Coloration of the film and NO release were found to scale with the percent of nitrosated-
MPTMS incorporated in the sol.  Thermal-initiated NO release from highly RSNO-modified 
films maintained NO fluxes >0.5 pmol cm-2 s-1 for up to 14 d in 37 °C phosphate-buffered 
saline (PBS).  The RSNO-modifed xerogels demonstrated excellent solution stability as 
negligible siloxane network fragmentation was observed during 2 week immersion in 37 °C 
PBS.  Significant reductions in adhesion of both Pseudomonas aeruginosa and activated 
porcine platelets were observed on nitrosated films versus non-nitrosated controls, indicating 
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that RSNO-modified films are capable of providing similar biocompatibility benefits as other 
NO-releasing xerogels. 
In Chapter 4, the unique properties of aminoalkoxysilane-derived xerogels were 
employed to create the first reported optical sensor coatings for quantitative determination of 
nitroxyl (HNO), the one-electron reduced congener of NO.  Sensors were created by 
encapsulating manganese(III) meso-tetrakis(4-sulfonatophenyl) porphyrinate (MnIIITPPS) in 
(aminoethylaminomethyl)phenethyltrimethoxysilane (AEMP3)/MTMOS xerogel films.  
Upon reaction with HNO, the reductive nitrosylation of MnIIITPPS to MnII(NO)TPPS 
resulted in a concurrent shift in the absorbance spectrum of the complex.  While the 
nitrosylated compound was unstable in air, encapsulation of MnII(NO)TPPS in the anaerobic 
interior of the AEMP3/MTMOS xerogel significantly slowed reoxidation of the complex.  
Thus, xerogel-encapsulated MnIIITPPS operated as a cumulative HNO trap over short time 
scales.  Sensor calibration was achieved by spectroscopically monitoring the initial rates of 
MnII(NO)TPPS formation in the films during exposure to the HNO-donor compound 
Angeli’s salt.  Steady-state kinetics were employed to compensate for HNO scavenging 
reactions and determine the kinetic coefficient (kon) of MnII(NO)TPPS formation in the 
xerogel environment.  The determined kon and spectroscopically observed rates of 
MnII(NO)TPPS formation were subsequently used to calculate HNO concentrations in 
sample solutions. 
Nitroxyl-sensing xerogel films were further optimized for use in a 96-well microtitre 
plate format through the incorporation of trimethoxysilyl-terminated poly(amidoamine-
organosilicon) (PAMAMOS) dendrimers.   The co-condensed PAMAMOS dendrimers 
selectively enhanced HNO diffusion through the material via the creation of hydrophilic 
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nanodomains in the siloxane network, resulting in greater kon values and increased overall 
HNO sensitivity of the films.  Amperometric oxygen permeability studies confirmed that 
PAMAMOS inclusion had no detrimental effect on the ability of the xerogel to exclude O2.  
Nitroxyl-sensing films containing 0.25% (v:v total silane) PAMAMOS were capable of 
resolving a minimum shift of approximately 10 nM HNO over a working dynamic range of 
24-290 nM HNO.  The developed 96-well microtitre sensor plates were subsequently used to 
characterize HNO-release from a recently described HNO/NO donor, sodium-1-
(isopropylamino)diazene-1-ium-1,2-diolate (IPA/NO), illustrating their potential as a useful 
tool in the evaluation of novel HNO donor compounds. 
 
5.2. Future Research Directions 
The optical sensing configuration employed in the development of the NO-releasing 
pH sensor described in Chapter 2 may be easily adapted for the fabrication of other NO-
releasing optical sensors.  Muller and co-workers have reported fiber-optic biosensors for 
penicillin, urea, creatinin and glucose created through immobilization of the appropriate 
enzyme (e.g., glucose dehydrogenase) at the surface of pH-sensitive optodes.1  As described 
previously, inert, porous xerogels provide a near ideal host matrix for enzyme encapsulation.  
Nitric oxide-releasing analogs of the four biosensors mentioned above could be created by 
coencapsulating a desired enzyme in the upper TMOS xerogel layer and monitoring pH 
changes associated with enzyme function through fluorescent emission of the SNARF-1 
indicator.  Replacing SNARF-1 with an alternate luminescent indicator for a desired analyte 
(e.g., phosphorescent erythrosin B for quenchometric oxygen detection2, 3) can also easily 
extend the capabilities of the two-layer xerogel optical sensor.  By bundling multiple NO-
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releasing xerogel-modified optical sensors together (i.e., O2, CO2, pH), biocompatible 
intravascular sensor arrays may be developed for real-time blood gas sensing during critical 
care situations. 
 A host of other intravascular sensor applications become possible if NO-release can 
be extended beyond the 16 h window achieved by the NONOate-modified xerogel films 
described in Chapter 2.  For example, a rapid drop in brain parenchyma pH has been reported 
by McKinley et al. during the onset of stroke.4  Detecting this pH shift in unconscious or 
comatose patients at high risk of stroke could be an important early warning sign used to 
reduce brain damage caused by ischemic insult.  Nitric oxide-releasing xerogels may provide 
a biocompatibility enhancement extending the functional lifetime of intravascular pH sensors 
used for long-term brain pH monitoring; prolonged durations of NO-release would be 
beneficial in such a task to reduce the necessary frequency of sensor replacement.  The 
RSNO-modifed xerogel films presented in Chapter 3 may be of potential use in this type of 
long-term sensing application. 
At present time, no RSNO-modifed polymeric coatings have been utilized for 
indwelling sensor applications.  While the pink coloration of RSNOs may pose problems for 
optical sensor platforms, the stability and extended duration of NO-release attainable by 
RSNO-modified xerogels makes them potentially well-suited as a membrane material for 
intravascular and subcutaneous electrochemical sensors.  Future work should evaluate the 
fabrication of RSNO-modified xerogel sensors and biosensors.  However, as the materials are 
still in the beginning stages of development, further characterization of RSNO-modified 
xerogel properties is required before practical application.   
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Membrane porosity and permeability is particularly important in electrochemical 
sensor applications.  As RSNO-modified xerogels are not exposed to the high pressures of 
NO required for NONOate formation, the extremely low porosity observed in NONOate-
modified xerogels attributed to free-radical catalyzed cross-linking should not be an issue.5  
Nevertheless, the permeability of RSNO-modified xerogels to common analytes (e.g., 
oxygen, glucose) should be assessed.  The choice of organoalkoxysilane precursors 
employed may have important effects on material permeability.  By utilizing silane 
precursors with highly branched terminal side chains or precursors subject to lower degrees 
of siloxane bonding (e.g., mercaptopropylmethyldimethoxysilane), more open and accessible 
xerogel networks may be created.   
Optimization of NO-release from RSNO-modifed xerogels remains largely to be 
explored.  For example, porous networks may be more accessible to acidified nitrite, 
resulting in increased thiol nitrosation and enhanced NO flux from the material.  The kinetics 
of thermal RSNO decomposition are influenced by factors such as the degree of substitution 
of the thiol-bonded carbon and/or presence of intramolecular hydrogen bonds.6  These 
structural considerations as well as other RSNO decomposition methods (e.g., light, Cu+)7 
should all be examined as a means of regulating NO flux and duration from RSNO-modified 
xerogels.   
Future work regarding the development of the HNO-sensing xerogel films described 
in Chapter 4 should focus on improving the working dynamic range and sensitivity of the 
optical sensors.  As the rapid dimerization reaction limits HNO concentrations in solution, 
expanding the usable range of the sensor must necessarily focus on decreasing current limits 
of HNO detection.  The most straightforward method of achieving this would be to improve 
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HNO complexation rates (i.e., kon) in the film.  While using alternate indicator molecules 
such as metmyoglobin8 or ferric porphyrins9 with higher reported rates of HNO reaction than 
the MnIIITPPS indicator employed may increase HNO complexation rates,  the determined 
values of kon for MnII(NO)TPPS formation in the xerogel films remain ~30-40 times lower 
than those reported by Marti et al. for MnIIITPPS in free solution.10  Thus the speed of HNO 
diffusion through the xerogel material likely plays a large role in determining the reaction 
rates observed.  The inclusion of small amounts of hydrophilic trimethoxysilyl-terminated 
PAMAMOS dendrimer effectively increased HNO permeation, but larger percentages of 
inclusion resulted in higher oxygen permeability and decreased sensor response.  The 
introduction of alternate sol-gel precursors for preferential enhancement of HNO over O2 
permeability in the xerogel may be required.  Accelerating HNO diffusion through the optical 
sensor films to increase kon and bring about concomitant improvements in HNO sensitivity 
while maintaining the anaerobic environments necessary for complex stability within the 
material remains a difficult and rewarding challenge. 
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Appendix 1: 
Antibacterial Properties of NO-Releasing Xerogel Microarrays 
 
A1.1. Introduction 
 Nitric oxide-releasing polymers have been shown to enhance the biocompatibility of 
intravascular and subcutaneous materials.1, 2  As a key element in vasodilation and the 
regulation of platelet activity and aggregation, NO has been used to substantially increase the 
thromboresistivity of blood-contacting biomaterials.3-5 Nitric oxide has also been linked to 
phagocytosis and the body’s response to microbial invaders.6  Polymeric coatings capable of 
NO-release have been shown to inhibit bacterial adhesion, suggesting that the use of such 
coatings for implant materials may aid in decreasing the incidence of implant-associated 
infection.7, 8  
A simple method of imparting NO-release capability to a polymer is through the 
inclusion of NO-donor moieties termed N-diazeniumdiolates. N-diazeniumdiolates are 
readily formed through exposure of diamine functional groups to high pressures of NO, 
resulting in the coordination of two NO molecules.9  This configuration remains stable until 
exposed to a proton donor such as water, which results in the decomposition of the N-
diazeniumdiolate and NO release.  Previously, xerogels have been demonstrated as useful 
matrices capable of controlled NO release.8  Through condensation of diaminoalkoxysilanes 
into the siloxane backbone of a xerogel network, xerogel coatings capable of tunable 
picomolar NO fluxes have been synthesized.10  
 For certain applications such as intravascular and subcutaneous electrochemical 
sensors, a uniform xerogel coating may not be ideal.  In such cases, the thromboresistive 
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benefits of NO-releasing polymers may be neutralized by the dense coating itself serving as 
an analyte diffusion barrier, resulting in decreased analytical sensitivity. Indeed, a recent 
study reported a greater than 104-fold decrease in  hydrogen peroxide permeation to a NO-
releasing xerogel-based glucose sensor.11 This problem may be alleviated by using 
micropatterning techniques to create NO-releasing xerogel arrays of micrometer dimensions 
separated by regions of unmodified sensor surface.  As such, NO diffusing from the xerogel 
microstructures may permit enhanced biocompatibility at the sensor’s surface while 
concurrently decreasing the analyte barrier effect caused by a uniform xerogel coating.  
Previous in vitro studies by Robbins et al. have shown that NO-releasing microarrays are 
capable of reducing platelet adhesion and activation.12   Recent work has confirmed these 
microarrays as a viable means of increasing the sensitivity and response of xerogel-modified 
electrochemical oxygen sensors.13  Herein, the antibacterial effects of micropatterned NO-
releasing xerogel arrays are evaluated.  Fewer adherent bacteria would correspond to a 
decrease in biofilm nucleation sites, implying that NO-releasing xerogel arrays may be useful 
in reducing biofouling and associated infection at an implant site.  Pseudomonas aeruginosa, 
an opportunistic pathogen, was selected as a model bacterium because of its medical 
relevance and capacity for biofilm formation.14  Reductions in bacterial adhesion to NO-
releasing xerogel microarrays were quantified relative to controls, and the effect of 
microarray geometry was examined.  
 
A1.2. Materials and Methods 
Methyltrimethoxysilane (MTMOS), (aminoethylaminomethyl)-
phenethyltrimethoxysilane (AEMP3), and dimethylsiloxane-(60% propylene oxide, 40% 
ethylene oxide) block polymer were purchased from Gelest (Morrisville, PA).  P. aeruginosa 
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(ATCC #19143) was obtained from American Type Culture Collection (Manassas, VA).  A 
BacLight LIVE/DEAD Cell Viability Fluorescence kit was purchased from Molecular 
Probes (Eugene, OR). Nitric oxide (99.5%) was acquired from National Welders Supply Co. 
(Durham, NC) and purified over KOH prior to use.  Distilled water was purified with a 
Millipore Milli-Q Gradient A-10 system (Bedford, MA) to 18.2 MΩ.  Sylgard 184 Silicone 
Elastomer (Dow Corning) polydimethylsiloxane (PDMS) and all other reagents were 
purchased from Fisher Scientific (Pittsburgh, PA) and used as received. 
 
A1.2.1. Xerogel Micropatterning  
A 20% AEMP3 / 80% MTMOS sol was prepared by mixing 160 µL MTMOS with 
200 µL ethanol (EtOH), 11 µL H2O and 40 µL of AEMP3.  The resulting mixture was 
immersed in an ultrasonic bath for 5 min. Xerogel microarrays were formed on glass 
substrates through the micromolding in capillaries (MIMIC) soft lithographic technique 
described by Whitesides and coworkers.15  Master molds with the desired array dimensions 
were photolithographically produced in a silicon (Si) wafer by MCNC (Research Triangle 
Park, NC). Elastomeric negative-relief templates were formed by fluorinating the Si master 
with (heptadecafluoro-1,1,2,2-tetra-hydrodecyl)-trichlorosilane vapor for approximately 45 
min to reduce PDMS adhesion,16 and then coating the master with Sylgard 184 elastomer and 
curing at 70 °C for 1 h. To enhance PDMS wettability toward the sol, the hydrophilicity of 
the PDMS channel walls was increased by immersing the PDMS templates in 5% PDMS-
polyethylene glycol (PEG) block polymer in EtOH (v/v) for 30 min.17  The PDMS templates 
were then rinsed with EtOH, dried, and brought into contact with a glass substrate, forming 
an array of microchannels with the dimensions of the original Si master features.  A 10 µL 
drop of the sol placed adjacent to this template was drawn into the microchannels by 
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capillary action and allowed to cure under ambient conditions for 24 h, after which the 
PDMS template was removed.  In this manner, arrays of lines 1.5 µm high with widths of 10 
or 50 µm and separation distances ranging from 10 to 200 µm were produced. 
 
A1.2.2. NO-Release 
N-diazeniumdiolate formation was achieved by exposure of the xerogel arrays to 5 
atm NO for 3 d in an in-house reactor, as described previously.10  Nitric oxide flux from the 
xerogel patterns was measured in deoxygenated phosphate buffered saline (PBS, 7.4 pH) at 
37 °C via chemiluminescence using a Nitric Oxide Analyzer 280 (Sievers Inc., Boulder, 
CO).   
 
A1.2.3. Array Stability 
The extended solution stability of the NO-releasing xerogel arrays was evaluated 
using a PicoPlus (Molecular Imaging, Tempe, AZ) atomic force microscope (AFM).  
Microarrays were incubated in PBS at 37 °C. After discrete immersion intervals, arrays were 
dried and contact-mode images were acquired using SiN3 AFM tips (nominal spring constant 
~ 0.12 N/m).    
    
A1.2.4. Evaluation of Bacterial Retention 
P. aeruginosa stocks were cultured in tryptic soy broth (TSB) at 37 °C, pelleted, 
washed, suspended in 15% glycerol, and stored at -80 °C until use.  Stocks were inoculated 
in TSB and grown for 12 h at 37 °C. A 1 mL aliquot of this culture was then grown in 200 
µL TSB at 37 °C  until the suspensions reached an optical density (ODλ=600) of 
approximately 0.2, corresponding to ~108 colony forming units (cfu) per mL. The bacteria 
were pelleted, washed, and resuspended in a BacLight Syto 9 / PBS solution for 30 min to 
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fluorescently stain the cells.  Following subsequent centrifugation and washing, the cells 
were resuspended in PBS.  Control and NO-releasing arrays were immersed in 37 °C PBS for 
30 min to initiate NO release. The samples were transferred to 5 mL bacterial suspensions at 
37 °C for an additional 30 min and agitated mildly (~ 1 rev/s).  The arrays were then rinsed 
lightly with deionized water to remove loosely adhered cells, and dried under a stream of 
nitrogen.  A Zeiss Axiovert 200 inverted microscope fitted with a Syto 9 optical filter and 
Zeiss Axiocam (Chester, VA) was utilized to image fluorescently-tagged bacteria retained on 
the arrays.  Bacterial surface coverage was determined through digital processing as percent 
white for each imaged 340 µm x 430 µm region.  For each array geometry, the average of 5 
randomly positioned images was determined for each of 9 sample arrays.  Overall surface 
coverage was determined as the mean of the 9 individual sample averages (n = 9). 
 
A1.3. Results and Discussion   
 The 20% AEMP3 / 80% MTMOS sol-gel formulation was employed because of the 
low sol viscosity afforded through use of the simple MTMOS precursor; which is necessary 
for MIMIC patterning procedures prior to curing.12  Chemiluminescence analysis verified 
that the N-diazeniumdiolate-containing arrays were capable of releasing NO.  After 
normalization to surface area, xerogel arrays were found to release NO at a flux of 
approximately 1.0 ± 0.1 pmol cm-2 s-1 over the 30 min time window of the bacterial adhesion 
studies. This flux is similar to the NO released endogenously by activated human endothelial 
cells (~6 pmol cm-2 s-1),18 and that reported previously to reduce bacterial adhesion via NO-
releasing xerogel films.7, 8  AFM images at distinct intervals after immersion in PBS solution 
(pH 7.4) at 37 °C indicated that the xerogel patterns were stable in aqueous solution for up to 
7 d (data not shown.) 
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 As shown in Figure A1.1, a marked decrease in adhesion to substrates was observed 
for NO-releasing xerogel arrays compared to non-releasing controls.  The veracity of this 
reduction was confirmed through ANOVA statistics. The average percent-surface covered by 
bacteria on controls, NO-releasing arrays, and the appropriate ANOVA P values for each 
group comparison are listed in Table A1.1.  The reduction in P. aeruginosa adhesion 
displayed for all arrays comprised of 50 µm lines was determined to be significant (P < 
0.05).  For these arrays, a reduction in adhesion of approximately 50% was noted for all 
arrays, regardless of line separation.  In 10 µm line arrays, a similar ~50% significant 
reduction was found for all line separations up to 50 µm.  At larger line separations, however, 
the apparent reduction begins to decrease and P begins to rise above the significance 
threshold (P > 0.05).  This is evident at 100 and 200 µm line separations. 
 These results may indicate a limit to the surface area of a substrate that may be left 
unmodified by xerogel under current experimental conditions.  It may be expected that for a 
given NO flux (herein 1.0 ± 0.1 pmol cm-2 s-1) there would exist a threshold ratio of 
unmodified/modified surface beyond which NO surface concentrations would be insufficient 
to achieve full inhibitory effects.  The apparent breakdown in significant reduction of 
bacterial adhesion on 10 µm line arrays separated by 100 and 200 µm may indicate that this 
limit is approached at a 10:1 unmodifed/modified surface ratio in this experiment.  The 
inherently high variability of bacterial adhesion onto a surface makes an absolute limit 
difficult to determine conclusively, however, as evidenced by the larger adherence reduction 
displayed at 150 µm separations.  In any case, such a threshold would depend heavily on 
experimental conditions (ie. substrate identity, NO flux, array geometry, etc.).  Maximization 
of line separation is desirable as bacteria tend to become trapped near the raised edge of a 
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Figure A1.1. P. aeruginosa adhesion on (A) control and (B) NO-releasing 10 µm 
xerogel lines separated by 50 µm spacings.  Cells are white. 
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Line width x Bacterial Coverage (%) ANOVA Line width x Bacterial Coverage (%) ANOVA 
separation 
(µm)a 
Control NO-arrayb P value separation  
(µm)a 
Control NO-arrayb P value 
10x10 9.3 ± 2.6 4.7 ± 1.4 2.3x10-4 50x10 8.8 ± 2.8 3.8 ± 1.8 4.4x10-4 
10x25 11.0 ± 2.4 5.2 ± 1.2 5.9x10-6 50x25 8.7 ± 3.2 3.3 ± 1.7 4.0x10-4 
10x50 9.2 ± 2.1 4.2 ± 0.9 6.7x10-6 50x50 7.5 ± 4.4 4.0 ± 2.3 4.1x10-2 
10x100 8.4 ± 3.5 6.0 ± 2.1 9.4x10-2 50x100 10.3 ± 3.2 5.6 ± 3.0 5.6x10-3 
10x150 10.2 ± 4.0 4.8 ± 2.0 2.5x10-3 50x150 9.6 ± 2.9 4.7 ± 1.6 4.5x10-4 
10x200 9.0 ± 4.7 6.1 ± 2.7 1.2x10-1 50x200 10.7 ± 1.4 5.2 ± 2.1 7.4x10-6 
a Line height = 1.5 µm.  b NO flux ~1.0 ± 0.1 pmol/cm2•s 
Table A1.1. Average bacterial surface coverage on 20% AEMP3 / 80% MTMOS 
xerogel arrays 
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xerogel line.  Thus, a reduction in the number of raised surfaces reduces the number of edges 
that may serve as potential biofilm nucleation sites.  
These results indicate that NO release from micropatterned arrays of xerogels 
effectively reduces the adhesion of P. aeruginosa to adjacent unmodified substrate regions. 
As such, the application of these arrays onto the surface of an implant may reduce biofouling 
while minimizing substrate modification. However, two factors must be considered further 
before extrapolation of these results to in vivo conditions.  As these experiments were 
performed in an aqueous cell suspension, NO degradation is limited to cellular interactions 
and direct oxidation to nitrite by dissolved O2.  In a biological environment, the presence of 
other NO scavengers (e.g., proteins, thiols, transition metals, etc.) is expected to significantly 
decrease the half-life of free NO.19  In such a situation, NO diffusion path lengths would be 
decreased, resulting in a reduction in the line separation distances that may be utilized while 
effectively maintaining NO concentrations adequate to impede bacterial adhesion.  It should 
also be noted that extremely large P. aeruginosa cell concentrations (108 cfu/mL) were used 
in this study to ensure regular substrate/cell interactions during the time of the experiment.  
The number of bacteria present would naturally be far lower in clinical situations.    
 
A1.4. Conclusions   
Arrays of xerogel lines capable of controlled release of NO via N-diazeniumdiolate 
modification have been produced through soft lithographic procedures.  These NO-releasing 
arrays proved capable of reducing P. aeruginosa adhesion to regions of unmodified glass 
substrates by approximately 50% at a NO flux of 1.0 ± 0.1 pmol cm-2 s-1 versus non-releasing 
controls in arrays comprised of unmodified/modified surface ratios up to 10:1.  As such, 
micropatterning NO-releasing xerogels may provide a valuable means for reducing the 
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biofouling of certain materials while concurrently maintaining portions of unmodified 
surface that required for implant function. 
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